Medical school in Boston, MA
POPULARITY
Categories
95 episodes with Harvard Medical School
97 episodes with Harvard Medical School
219 episodes with Harvard Medical School
38 episodes with Harvard Medical School
55 episodes with Harvard Medical School
31 episodes with Harvard Medical School
17 episodes with Harvard Medical School
22 episodes with Harvard Medical School
18 episodes with Harvard Medical School
24 episodes with Harvard Medical School
25 episodes with Harvard Medical School
31 episodes with Harvard Medical School
21 episodes with Harvard Medical School
35 episodes with Harvard Medical School
34 episodes with Harvard Medical School
20 episodes with Harvard Medical School
14 episodes with Harvard Medical School
13 episodes with Harvard Medical School
26 episodes with Harvard Medical School
22 episodes with Harvard Medical School
12 episodes with Harvard Medical School
11 episodes with Harvard Medical School
57 episodes with Harvard Medical School
19 episodes with Harvard Medical School
18 episodes with Harvard Medical School
9 episodes with Harvard Medical School
18 episodes with Harvard Medical School
15 episodes with Harvard Medical School
29 episodes with Harvard Medical School
32 episodes with Harvard Medical School
8 episodes with Harvard Medical School
19 episodes with Harvard Medical School
11 episodes with Harvard Medical School
10 episodes with Harvard Medical School
12 episodes with Harvard Medical School
9 episodes with Harvard Medical School
11 episodes with Harvard Medical School
14 episodes with Harvard Medical School
11 episodes with Harvard Medical School
22 episodes with Harvard Medical School
8 episodes with Harvard Medical School
11 episodes with Harvard Medical School
14 episodes with Harvard Medical School
14 episodes with Harvard Medical School
11 episodes with Harvard Medical School
8 episodes with Harvard Medical School
18 episodes with Harvard Medical School
10 episodes with Harvard Medical School
12 episodes with Harvard Medical School
10 episodes with Harvard Medical School
12 episodes with Harvard Medical School
11 episodes with Harvard Medical School
20 episodes with Harvard Medical School
15 episodes with Harvard Medical School
I want to start off by asking a question I continually interest myself with. Do we really want to be happy? If I survey the culture, it looks like we very much want happy moments. The little jolts of dopamine from entertainment, food, drugs and such. But do we really want deep and abiding happiness in our souls? Because if we do, then our primary interest would be in relationships. But not just any relationships. I'm revisiting a conversation I had with Robert Waldinger. Robert is a professor of psychiatry at Harvard Medical School and director of the Harvard Study of Adult Development at Massachusetts General Hospital which has been going on for 87 years. His devotion is on what most equates to human happiness, and the answer is, relationships. But let me point out that Robert himself is a Zen master and teaches meditation around the world. Which is a focus on what I feel is our first and most important relationship. The relationship with ourselves. I have continued to grow in appreciation, not just for the message, but for Robert himself. If you have my book, What Drives You, you'll see his endorsement. Roberts book, which is how I came to know of him, is, The Good Life: Lessons From the World's Longest Scientific Study on Happiness. And you type in, “Robert Waldinger TED” you will find his TED talk, titled, What Makes A Good Life, that between postings on both YouTube and TED has over 80 million views. Sign up for your $1/month trial period at shopify.com/kevin Go to shipstation.com and use code KEVIN to start your free trial. Learn more about your ad choices. Visit megaphone.fm/adchoices
Most of us have been trained to think of treating people as a technical problem. If something hurts, we look for the right drug. If something fails, we look for the right procedure. That picture is incomplete.We've built a system obsessed with fixing bodies, while quietly ignoring the inner worlds of the people living inside them. Their fears, their beliefs, their unanswered prayers, and the meaning they're trying to make of suffering.Illness doesn't just attack organs. It raises questions about God, identity, guilt, fear, and loss of control. And when those questions go unanswered, suffering multiplies, no matter how advanced the treatment plan is.Modern medicine has no real language for this kind of pain. It knows how to measure blood pressure, inflammation, and tumor size, but it doesn't know how to sit with grief, spiritual doubt, uncertainty, and loss.Yet when clinicians slow down enough to listen, something shifts. Patients begin to speak about meaning, about God, about unresolved relationships and fears they've never voiced before.And often, that is where real healing starts — the kind of whole-person healing that restores connection, dignity, and a sense of being spiritually held in the middle of suffering.What if some of the deepest healing doesn't come from doing more, but from being more present? How can clinicians learn to care for the soul as intentionally as they care for the body?In this episode, I speak with Dr. Marvin Delgado Guay, a palliative care specialist at MD Anderson Cancer Center. We talk about what it looks like when medicine includes spiritual care in its everyday practice. We explore why “total pain” includes the soul as much as the body, and how healthcare can become not just a place of treatment, but a space for healing, meaning, and connection with God.Things You'll Learn In This Episode Pain isn't always physicalMany symptoms labeled as “medical” are actually expressions of emotional or spiritual distress. What happens when we treat suffering instead of just symptoms?Fixing vs. healingMedicine is trained to solve problems, but some forms of suffering can't be solved, only witnessed. How does presence become a form of treatment?How spirituality shapes medical decisionsBeliefs about meaning, God, and purpose influence everything from treatment choices to end-of-life care, but are clinicians equipped to address this?The power of the “collective soul” in healthcareWhen doctors, nurses, chaplains, and therapists work as one, care becomes something deeper than specialization. What changes when healing becomes a shared human act?Guest BioDr. Marvin Delgado Guay is an internist and Assistant Professor in the Department of Palliative Care and Rehabilitation Medicine at MD Anderson Cancer Center, where he provides symptom control and supportive care for patients with advanced cancer and their caregivers. He completed his internal medicine training at Michael Reese Hospital in Chicago, followed by a fellowship in Geriatric Medicine at Harvard Medical School, and a clinical and research fellowship in Symptom Control and Palliative Care at MD Anderson. Earlier in his career, he coordinated palliative care services and worked within geriatrics at Lyndon B. Johnson General Hospital through the University of Texas Medical School. Dr. Delgado Guay's work focuses on what medicine often overlooks: the full experience of illness. His research explores physical, psychological, and spiritual distress in patients with serious disease, as well as aging-related issues such as frailty and cognition. He has authored and co-authored multiple peer-reviewed publications on symptom burden and spiritual care in advanced cancer, and is deeply committed to improving quality of...
Medicare for all. Not socialized medicine, just a single, government-run system that provides healthcare. Is it possible? Or even viable? Our guest this week on the Creating a New Healthcare podcast believes so. In fact, he sees it as the only way to ultimately address the affordability problem with healthcare, particularly for high cost conditions like cancer. In today's episode, we talk with Dr. Troy Brennan about his book, The Transformation of American Health Insurance: On the Path to Medicare for All, and why a single payer, government system is needed, and how the changes the current administration has made to our public health systems is taking us backwards, not forward. Troyen Brennan is an Adjunct Professor at Harvard Chan School of Public Health. He was formerly the Executive Vice President and Chief Medical Officer for CVS Health and Aetna. Before that, he was the President of the Brigham and Women's Physician Organization and Professor of Medicine at Harvard Medical School. He was also Professor of Law and Public Health at the Harvard Chan School of Public Health. Brennan was formerly the Chair of the American Board of Internal Medicine and is a member of the National Academy of Medicine. He has published six books and over 600 articles.
In this episode, Dr. Andy Cutler talks with Dr. Tim Wilens about enduring myths surrounding ADHD diagnosis and treatment, beginning with why misconceptions about overdiagnosis and misuse continue to shape clinical hesitation. They explore common misunderstandings about ADHD medications—including stimulants versus non-stimulants, concerns about diversion, personality changes, and long-term safety—and contrast stigma-driven narratives with the clinical evidence. The conversation equips clinicians with practical, evidence-based strategies to address patient fears, counter misinformation, and make thoughtful, individualized treatment decisions. Timothy Wilens, MD, is chief of the Division of Child and Adolescent Psychiatry and is co-director of the Center for Addiction Medicine at Massachusetts General Hospital. He is the MGH Trustees Chair in Addiction Medicine and a professor of psychiatry at Harvard Medical School. Dr. Wilens' research interests include the relationship among attention deficit/hyperactivity disorder (ADHD), bipolar disorder, and substance use disorders, embedded health care models, and the pharmacotherapy of ADHD across the lifespan. Andrew J. Cutler, MD, is a distinguished psychiatrist and researcher with extensive experience in clinical trials and psychopharmacology. He currently serves as the Chief Medical Officer of Neuroscience Education Institute and EMA Wellness. He is a Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University in Syracuse, New York. Save $100 on registration for 2026 NEI Spring Congress with code NEIPOD26 Register today at nei.global/spring Never miss an episode!
Read "ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature" – co-authored by Dr. Anthony L. Komaroff & W. Ian Lipkin. https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2023.1187163/full Fatigue is the body's hard-wired response to a viral infection. In today's episode, Haylie Pomroy shares insights with Dr. Anthony L. Komaroff to examine the history of ME/CFS research, the causes and triggers of ME/CFS and other post-infectious chronic illnesses, and the abnormalities observed in the brain and autonomic nervous system among patients with ME/CFS and long COVID. Dr. Komaroff also addresses how patients have often been dismissed within the healthcare system, explains the physical and psychological processes involved in these conditions, and discusses how he and other clinicians are now moving to the forefront of diagnosis and treatment. Register for the Integrative Medicine Luncheon featuring Dr. Payam Hakimi on February 14, 2026. https://nova.zoom.us/meeting/register/RQnykYIKRZO-yVykmDp-YQ#/registration Dr. Anthony L. Komaroff is a distinguished Professor of Medicine at Harvard Medical School and a Senior Physician at Brigham and Women's Hospital. He has held significant leadership roles, including Director of the Division of General Medicine and Primary Care at Brigham and Women's Hospital. Dr. Komaroff is known for his research on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and human herpesvirus infections. He has published over 270 research articles and book chapters and served on numerous advisory committees for major health organizations. LinkedIn: https://www.linkedin.com/in/anthony-l-komaroff-64133346/ Facebook: https://web.facebook.com/anthonyl.komaroff Solve ME: https://solvecfs.org Open Medicine Foundation: https://www.omf.ngo National Institutes of Health (NIH): https://www.nih.gov/mecfs/about-mecfs Centers for Disease Control and Prevention (CDC): https://www.cdc.gov/me-cfs/about/index.html Haylie Pomroy, Founder and CEO of The Haylie Pomroy Group, is a leading health strategist specializing in metabolism, weight loss, and integrative wellness. With over 25 years of experience, she has worked with top medical institutions and high-profile clients, developing targeted programs and supplements rooted in the "Food is Medicine" philosophy. Inspired by her own autoimmune journey, she combines expertise in nutrition, biochemistry, and patient advocacy to help others reclaim their health. She is a New York Times bestselling author of The Fast Metabolism Diet. Learn more about Haylie Pomroy's approach to wellness through her website: https://hayliepomroy.com Instagram: https://www.instagram.com/hayliepomroy Facebook: https://www.facebook.com/hayliepomroy YouTube: https://www.youtube.com/@hayliepomroy/videos LinkedIn: https://www.linkedin.com/in/hayliepomroy/ X: https://x.com/hayliepomroy Enjoy our show? Please leave us a 5-star review so we can bring hope and help to others. You can also watch the show on our YouTube.https://www.youtube.com/@NSU_INIM Sign up today for our newsletter. https://nova.us4.list-manage.com/subscribe?u=419072c88a85f355f15ab1257&id=5e03a4de7d This podcast is brought to you by the Institute for Neuro-Immune Medicine. Learn more about us here. Website: https://www.nova.edu/nim/ Facebook: https://www.facebook.com/InstituteForNeuroImmuneMedicine Instagram: https://www.instagram.com/NSU_INIM/ Twitter: https://www.twitter.com/NSU_INIM
Synopsis: At JPM 2026 in San Francisco, Alok Tayi welcomes Michelle Werner, CEO of Alltrna, to Biotech 2050 for a powerful conversation at the intersection of personal mission, platform biology, and rare-disease drug development. Michelle traces her two-decade career across Bristol Myers Squibb, AstraZeneca, and Novartis—and the moment everything changed when her child was diagnosed with a rare disease. That experience led her to Alltrna and its pioneering engineered tRNA platform, designed to correct nonsense mutations across hundreds—potentially thousands—of genetic disorders with a single therapeutic approach. Together, Alok and Michelle explore how tRNAs work, why “stop-codon disease” could redefine rare-disease classification, and how basket trials borrowed from oncology may accelerate development. They dive into delivery strategy, portfolio expansion into CNS and muscle disorders, regulatory innovation, and how AI is reshaping molecular design—offering a rare look at what it takes to build a first-in-class modality from the ground up. Biography: Michelle is a seasoned pharmaceutical executive with more than 20 years in the industry spanning commercial and research & development (R&D) responsibilities. Prior to Alltrna, Michelle served as Worldwide Franchise Head, Solid Tumors at Novartis Oncology, where she was responsible for delivering the disease area strategies across multiple tumors and led business development efforts resulting in a doubling of long-term portfolio value for the franchise. Previous to Novartis, Michelle was a senior leader at AstraZeneca and as Global Franchise Head in Hematology, she was critical in launching multiple indications worldwide for CALQUENCE®. Prior to this, Michelle was Head of US Oncology, where she led the business through dramatic growth in both team and revenue through eight-plus product launches. Previous to AstraZeneca, Michelle was with Bristol-Myers Squibb for 10 years in various positions of increasing responsibility including roles in sales, marketing, and market access in the US and UK, and above market in Europe (based in France) and global almost exclusively in oncology. Michelle started her professional career in R&D, working hands-on with patients at the Oncology Clinical Trials Unit at Harvard Medical School before moving into industry in clinical operations. Outside of her corporate responsibilities, Michelle is a wife and mother to three children and is a member of the rare disease community. She is currently serving a Board appointment for the non-profit organization Rare Disease Renegades, a purpose that fuels her passions both personally and professionally.
In episode 67 of Going anti-Viral, Dr Martin Hirsch joins host Dr Michael Saag to discuss his career in HIV medicine, mentorship, and his scientific legacy. Dr Hirsch is a Professor Emeritus at Harvard Medical School and was Director of the Harvard Collaborative AIDS Treatment Evaluation Unit from 1986 to 2003 and Director of the Harvard Multidisciplinary AIDS Research Training Grant. Dr Hirsch's research focused on finding drug combinations that delay the development of multidrug resistance and reduce viral replication in HIV-1 infection. Dr Hirsch served as an Editorial Board member for numerous prestigious medical journals over the past 3 decades, including AIDS, the New England Journal of Medicine, Clinical Infectious Diseases, and the Journal of Infectious Diseases, where he was Editor-in-Chief. Dr Hirsch discusses his extensive career, the evolution of antiviral therapies, and the importance of mentorship in science. He reflects on his early experiences, the emergence of HIV, and the collaborative efforts that led to advancements in treatment. Dr Hirsch emphasizes the need for individualized mentorship and shares insights on the future of HIV research and his optimism for the potential of HIV prophylactic treatments.0:00 – Introduction1:50 – Early career and mentorship5:07 – Transitioning to HIV research7:55 – The emergence of antiretroviral therapies11:06 – The AIDS epidemic and initial cases14:30 – Collaboration in HIV research17:42 – The AZT trial and its impact20:16 – Navigating the shift from CMV to HIV22:39 – Antiretroviral resistance and combination therapy26:39 – The role of mentorship in science30:56 – Future directions in HIV researchResources:Going-anti-Viral: Episode 6 - A Conversation With Dr Anthony Fauci __________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...
In this episode, Dr. Greg Jones sits down with Dr. Sharon Hausman-Cohen, Chief Medical Officer of IntelliXX DNA, to explore how medical genomics is transforming the way we understand heart disease, brain health, inflammation, and metabolism. Most people think genetics stops at traits like eye color or ancestry. Genomics goes much deeper—analyzing how thousands of genes interact to influence cardiovascular risk, cognitive function, clotting tendencies, nutrient metabolism, and chronic inflammation.Dr. Hausman-Cohen explains why many direct-to-consumer DNA tests fall short, how incomplete interpretation can mislead patients, and why clinician-guided genomic analysis allows for truly personalized care. The conversation also dives into inflammation, methylation, homocysteine, cholesterol myths, caffeine metabolism, mitochondrial health, and women's unique clotting risks.Whether you're trying to reduce your risk of heart disease, improve mental clarity, or understand how your biology responds to diet, supplements, and medications—this episode offers a science-based roadmap for precision health.
Send us a textNavigating Childhood Tics and Tourette Syndrome: Expert Insights with Dr. GreenbergIn this episode, we sit down with Dr. Greenberg, director of the pediatric psychiatry OCD and Tic disorders program in Boston, to discuss the complexities of childhood tics and Tourette Syndrome. Dr. Greenberg shares his extensive expertise and personal experiences to help parents understand what tics are, how they manifest, and their natural progression. He provides insights on effective treatments such as CBIT therapy and when medication might be necessary. Additionally, Dr. Greenberg emphasizes the importance of differentiating between normal tics and those that may indicate other co-occurring conditions like ADHD and OCD. This episode is a must-watch for parents seeking reassurance and practical advice on managing their child's tics.Erica Greenberg, M.D. is an assistant Professor in Psychiatry at Harvard Medical School and a child/adolescent psychiatrist at Massachusetts General Hospital (MGH) where she is the Director of the Pediatric Psychiatry OCD and Tic Disorders Program. Dr. Greenberg is also a co-Director of the MGH Tourette Association of America (TAA) Center of Excellence and the co-president of the Medical Advisory Board of the TAA. Her interests include Tourette syndrome (TS), OCD, “Tourettic OCD,” ADHD, body-focused repetitive behavior disorders, and other Tourette syndrome spectrum conditions. She has authored several peer-reviewed manuscripts on TS, OCD, and related disorders, and has presented on these conditions nationally and internationally. Dr. Greenberg graduated from Weill Cornell Medical College with Alpha Omega Alpha honors, and completed her general psychiatry residency at Harvard Longwood and her child/adolescent fellowship training at MGH.Contact Dr Greenberg: MassGeneral Brigham; Massachusetts General Hospital for ChildrenPediatric Psychiatry OCD and Tic Disorders ProgramEmail: MGHPediOCDTics@partners.org617-643-2780Your Child is Normal is the trusted podcast for parents, pediatricians, and child health experts who want smart, nuanced conversations about raising healthy, resilient kids. Hosted by Dr. Jessica Hochman — a board-certified practicing pediatrician — the show combines evidence-based medicine, expert interviews, and real-world parenting advice to help listeners navigate everything from sleep struggles to mental health, nutrition, screen time, and more. Follow Dr Jessica Hochman:Instagram: @AskDrJessica and Tiktok @askdrjessicaYouTube channel: Ask Dr Jessica If you are interested in placing an ad on Your Child Is Normal click here or fill out our interest form.-For a plant-based, USDA Organic certified vitamin supplement, check out : Llama Naturals Vitamin and use discount code: DRJESSICA20-To test your child's microbiome and get recommendations, check out: Tiny Health using code: DRJESSICA The information presented in Ask Dr Jessica is for general educational purposes only. She does not diagnose medical conditi...
Sergio Alfaro, Army Medic and GWOT veteran, in Episode 234 of the Transition Drill Podcast, his experience highlights the importance of preparing for the mental and emotional side of transition, not just the next job or degree, and building support systems early instead of relying on a single post-service plan. Ultimately, his path reinforces that successful transition preparation requires adaptability, self-awareness, and permission to redefine success when the original mission no longer fits.Sergio talks about Iraq, PTSD, and the long road from wanting to become a doctor to rebuilding a life that actually works. If you're a veteran or first responder trying to figure out who you are after the job, this one's for you.Sergio was born in Los Angeles and grew up in Maywood and Burbank, seeing two very different worlds early on. He joined the Army with a long-term plans of becoming a doctor. In the Army, he became a medic, trained and deployed to Iraq in 2003–2004, based in Hamadi, west of Fallujah. He describes the reality of frequent mortar attacks, watching for IED threats, and the kind of moments that never really leave you. He also shares the loss of his commanding officer overseas, and how survivor's guilt and “why him, not me” thinking followed him home.After one enlistment, that turned into four and a half years because of stop-loss, Sergio struggled with trauma, but was hopeful of getting the option for the Army to send him to college to be a doctor. He wanted to keep serving and also go to school, but he ran into the “ask command” reality of the system, and it changed his outlook on staying in. He got out, determined to chase the goal on his own terms.That drive carries him all the way to acceptance at Harvard Medical School, with the GI Bill and Yellow Ribbon support helping make it possible. But also dealing with PTSD, a medical culture not built for that, and a training path that puts him in a VA inpatient psych ward rotation at the worst possible time. Things spiral, and he shares what it's like when your identity is tied to one mission and you feel it slipping away.The second half of this conversation is about what actually helped: support systems, weekly check-ins, and eventually getting connected with Wounded Warrior Project's Warriors to Work, job fairs, resume feedback, and a shift toward a new career path built around what he always loved most, training and teaching others.CONNECT WITH THE PODCAST:Instagram: https://www.instagram.com/paulpantani/WEBSITE: https://www.transitiondrillpodcast.comLinkedIn: https://www.linkedin.com/in/paulpantani/SIGN-UP FOR THE NEWSLETTER:https://transitiondrillpodcast.com/home#aboutQUESTIONS OR COMMENTS:paul@transitiondrillpodcast.comSPONSORS:GRND CollectiveGet 15% off your purchaseLink: https://thegrndcollective.com/Promo Code: TRANSITION15Blue Line RoastingGet 10% off your purchaseLink: https://bluelineroasting.comPromocode: Transition10Frontline OpticsGet 10% off your purchaseLink: https://frontlineoptics.comPromocode: Transition10
Love the episode? Send us a text!What happens when a breast surgeon becomes a breast cancer patient—and then faces a second diagnosis years later?In this deeply personal and illuminating episode of Breast Cancer Conversations, host Laura Carfang is joined by Dr. Anne Peled, a board-certified breast, reconstructive, and plastic surgeon who has treated thousands of patients—and also navigated her own early-stage breast cancer diagnosis, followed years later by a new primary DCIS diagnosis.Together, Laura and Dr. Peled unpack what patients are rarely told about DCIS (stage zero breast cancer), the difference between recurrence and a second primary cancer, and how advances in surgery are transforming survivorship—including sensation-preserving mastectomy.This conversation bridges clinical expertise and lived experience, offering clarity, compassion, and permission to choose the path that aligns with your body and values.In this episode: What DCIS really is—and why “stage zero” can be misleadingRecurrence vs. second primary breast cancer: why biology mattersLumpectomy vs. mastectomy and why survival outcomes are often the sameHow guilt and self-blame show up after a second diagnosisBeing diagnosed with breast cancer as a physicianNavigating treatment when your colleagues are your caregiversThe evolution of oncoplastic surgery and patient-centered careWhy loss of breast sensation is under-discussed—but life-changingHow sensation-preserving mastectomy worksWhat questions to ask your surgeon about sensation, nerves, and recoveryMaking decisions based on your priorities—not fear or pressureAbout today's guestDr. Anne Peled is a board-certified plastic, reconstructive, and breast surgeon in private practice in San Francisco and Co-Director of the Sutter Health California Pacific Medical Center Breast Cancer Center of Excellence. Trained at Amherst College, Harvard Medical School, and UCSF, Dr. Peled completed a unique fellowship combining breast oncologic surgery and reconstruction.Her clinical and research work focuses on oncoplastic surgery, preserving and restoring sensation after mastectomy, improving patient outcomes, and breast cancer risk reduction. She is also a breast cancer survivor herself, bringing rare dual insight to patient care. Support the showLatest News: Become a Breast Cancer Conversations+ Member! Sign Up Now. Join our Mailing List - New content drops every Monday! Discover FREE programs, support groups, and resources! Enjoying our content? Please consider supporting our work.
Imagine being afraid of a pickle. Or a banana. Or a nub of bread. That’s daily life for people with ARFID (Avoidant/Restrictive Food Intake Disorder). It's an eating disorder not driven by weight or body image, but by fear, sensory overwhelm, or low appetite. People with this condition experience real terror and powerful aversions to certain foods - far beyond picky eating. Clinical psychologist Dr. Evelyna Kambanis explains ARFID, who it affects, and how treatment helps people reclaim their lives. Andrew Luber (aka “ARFID Andrew”) shares his funny, blunt, and vulnerable attempts at food exposures online. And Danielle Meinert tells the story of carrying ARFID since toddlerhood, and the startling change she says came after a high-dose psilocybin experience. Resources: National Eating Disorders Association - ARFIDAssociation of Anorexia Nervosa and Associated DisordersFamilies Empowered and Supporting Treatment of Eating Disorders Suggested episodes: The hidden hunger of Pica: Stories from people who eat objects Anorexia is complex. Two people talk frankly about their decades-long journeys GUESTS: Dr. Evelyna Kambanis: Licensed clinical psychologist in the Eating Disorders Clinical & Research Program at Massachusetts General Hospital and a faculty member at Harvard Medical School. She is involved in clinical care and research on ARFID Andrew Luber, aka ARFID Andrew: Los Angeles filmmaker and social media creator who documents food exposures with humor under the tagline, “Conquering my fear of food one laugh at a time” Danielle Meinert: Lived with ARFID for 27 years after a major shift in her relationship with food following ear surgery as a toddler. After years of trying traditional approaches, she described experiencing a dramatic change after a session using psilocybin Support the show: https://www.wnpr.org/donateSee omnystudio.com/listener for privacy information.
“Time of Useful Consciousness “ (The aviation term for the time between when the oxygen cuts out, and the pilot is still conscious…) Caroline welcomes astro mytho colleague Judith Tsafrir, as we weave powerful testimony from Aliya Rahman, and Renee Good's brothers, Luke & Brent Ganger, rousing music – with the increasing rapidly arising dangers – with the descriptive & guiding astrological narrative of effective strategy. The Good Medicine of Bad Bunny Super Bowl, the Monks and Aloka. In Trickster We Trust … Judy Tsafrir, MD is a physician, shamanic practitioner, and guide in the work of healing and human development. Trained in adult and child psychiatry and psychoanalysis, and a longtime Harvard Medical School faculty member, she brings an integrative approach that bridges depth psychology, holistic medicine, and spiritual wisdom. Judy draws on shamanism, astrology, the Tarot, Reiki, and intuitive practices, alongside her medical and psychoanalytic training, to support healing at emotional, physical, and spiritual levels. She is the author of Sacred Psychiatry: Bridging the Personal and Transpersonal to Transform Health and Consciousness., and her work is grounded in the belief that healing arises through the integration of heart, mind, body, and spirit—and that personal healing is inseparable from the healing of our communities and planet. https://www.JudyTsafrirMD.com The post Time of Useful Consciousness appeared first on KPFA.
Dr. Monty Pal and Dr. Atul Batra discuss the PLANeT study from India, which evaluated low-dose pembrolizumab in addition to neoadjuvant chemotherapy for triple-negative breast cancer, and its place among a growing body of international research on improving efficacy while reducing costs and toxicity with lower doses of immunotherapy. TRANSCRIPT Dr. Monty Pal: Hello and welcome to the ASCO Daily News Podcast. I'm your host, Dr. Monty Pal. I'm a medical oncologist, professor, and vice chair of academic affairs at the City of Hope Comprehensive Cancer Center, Los Angeles. My guest today, I think, is going to be a really riveting one. It's Dr. Atul Batra, who is an additional professor of medical oncology at the All India Institute of Medical Sciences, or AIIMS, in New Delhi. And he's also the senior author of the PLANeT study. It's a very compelling study that evaluated low-dose pembrolizumab in addition to neoadjuvant chemotherapy for triple-negative breast cancer. And it's really a big part of a growing body of research that's showing balanced efficacy when we use lower doses of immunotherapy instead of standard doses to reduce cost, as well as potentially toxicity. I think this has huge implications for our global audience, and I'm so thrilled to have you on the podcast today, Dr. Atul Batra, welcome. Dr. Atul Batra: Thank you, Dr. Pal. Dr. Monty Pal: And we'll just take it with first names from here since we're both friends. I have to give the audience some context. Atul, I had the great honor of visiting AIIMS New Delhi. For those that don't know, this is really, you know, the Harvard Medical School of India. It's the most competitive institution for medical training. And on the back end of that, there's also incredible resources when it comes to clinical trials and infrastructure. I just wanted to have you give the audience sort of a scope of the types of trials that you've been able to do at AIIMS New Delhi. Dr. Atul Batra: Thank you, Monty. So, I work at the All India Institute of Medical Sciences, and we had the honor and pleasure of having Monty here this month. And people are still in awe of his lectures that he delivered there. Coming back to our institute, so it's kind of a medical college. It's one of the oldest ones, it was built in 1956. We are lucky enough that we get the best of the residents and fellows because they have to go through an exam, a competitive exam, and mostly it's them who come to us and we're able to do some good work out here. Regarding the trials that we have conducted, we do conduct some investigator-initiated studies, and we try to answer the questions where we can help our own patients. Like, for example, this PLANeT study. Every other patient in the clinic was almost not able to afford Keytruda at the full dose, pembrolizumab, and we had a lot of evidence creeping in that a lower dose might be helpful. And that's how we planned this study. Before that, there are certain cancers that are peculiar to India, like gallbladder cancer, head and neck cancers. These are much more common in India as compared to the U.S., and there are some good studies that have been conducted from our own institute by our senior colleagues which have been presented at ASCO and published in the JCO. We also did the capecitabine hand-foot syndrome study that was known as the D-ToRCH study: 1% diclofenac gel that became the standard of care to prevent hand-foot syndrome. So, that's kind of a brief overview of investigator-initiated studies. India is slowly and steadily becoming a partner of the global registration trials. And it's more recently, the last five years or so, we have seen that the number of phase 2 and phase 3 trials are increasing and we are able to offer now these trials as well to our patients. Dr. Monty Pal: That was a terrific overview. I just want to highlight for the audience, as we go through some of your discussions today around specific trials, the speed at which this can be done. Just for context, for me to accrue a clinical trial of 30 patients – I think many people have probably come across some of the work that I've done in the microbiome space – at a single institution, 30 patients, right, takes me about a year and a half, two years. We're going to go through some trials today where Dr. Batra and his team have actually, in fact, accrued close to 200 patients over a span of just a year, which is just remarkable by, I would say, any American standard. So, I see a real need for partnership and Atul, I'll kind of get back to that at the end. But without further ado, the focus of this podcast today, I think, is really this terrific presentation you gave in an oral session at ESMO and subsequently published in Annals of Oncology related to the PLANeT study. Would you give the listeners some context around what the study entailed and population and so forth? Dr. Atul Batra: So, we know the KEYNOTE-522 became the standard of care for triple-negative breast cancer, where Keytruda, when added at 200 mg, the standard dose every three weeks with neoadjuvant, increases the pCR from around 51% to 64% by a magnitude of around 13%. However, in India and other low-middle income countries, less than 5% of the patients actually have access to this dose of pembrolizumab. So, our standard of care was actually just chemotherapy till now. And this kind of led us to design this trial. There are data that come from previous trials conducted in India, from the Tata Memorial, done in head and neck space, some other studies done in Hodgkin's lymphoma, that a much lower dose, probably around one-tenth of the dose, works well in these cancers. So, that's where we designed the PLANeT study, where we gave the standard neoadjuvant chemotherapy in the control arm, and in the experimental arm we added 50 mg of pembrolizumab. This was given every six weeks for three doses. So, that's a total of 150 mg over the neoadjuvant period as compared to 1,600 mg that was given in the KEYNOTE-522 study. So, this was almost one-tenth of the study. Dr. Monty Pal: So, a tenth of the dose, which is just remarkable. I mean, that's just such an interesting concept. Dr. Atul Batra: And the results, when we – the primary outcome, this was a phase 2 study. We just wanted to see, is there a signal of activity? And to even our surprise, when we looked at the pathological complete response rates, in the control arm this was 40.5%, and in the experimental arm this was 53.8%. So, a difference came to around 13.3%; it was numerically, I mean, so much similar to what KEYNOTE-522 had with just these many doses. So, this was around 160 patients randomized over one year. We could randomize them in one year because of the load that we see. And the primary endpoint was met, and we could see that the path complete response did show a remarkable increase. We are still following these patients to see whether there is a difference in event-free survival at a longer follow-up. Until now, it's a small follow-up, so the number of events absolute, are different: four events in the experimental arm and 11 events in the control arm. So, we are seeing some signal even in this much short follow-up period as well. But we need to see more of what happens in the longer term. Dr. Monty Pal: That's so impressive. I wonder, with this lower dose, do you attenuate toxicity at all as far as you can gather? Dr. Atul Batra: So, although we shouldn't be doing kind of cross-trial comparisons, but if you look at thyroid dysfunction, we saw that around 10% of our patients had this thyroid dysfunction. This was compared to 15% in the KEYNOTE-522, that was a larger sample size though. But we're seeing that all the toxicities are somewhat less as compared to those in the standard dose. So, the exposure is less, but I mean, I can't really commit definitely on this. For this we would need much more data to say this with more confidence. Dr. Monty Pal: Yeah. I'm going to ask you a really tough question to follow up, and this is probably something that's on everyone's mind after reading a study like this. Is this something that is disease-specific that needs to be replicated across other histologies? The reason I ask this is, you know, you think about paradigms like, for instance, in the States we're toying between intravenous versus subcutaneous delivery of checkpoint inhibitors, and we have studies focused in specific histologies that might justify use across all histologies. With this particular phenomenon, do you think we need to do dedicated studies in renal cell or in colon cancer and other places where, you know, in selected settings we might use checkpoint inhibitors and then decide whether or not there's this dose equivalence, if you will? Dr. Atul Batra: That's a real tough one, though. But I'm happy to share that there are several ongoing studies within India currently. At our institute, my colleagues are leading studies in lung cancer space, cervical cancer. There was already a publication from Tata Memorial Hospital in head and neck cancers and we see that the signal has been consistent throughout. Regarding renal cancer, there was one study that was presented for sure at ASCO from CMC Vellore, that's again a center in South India. That was in RCC at a much lower dose. And for patients who cannot take the full dose, we actually are offering lower dose nivolumab in such patients and we are seeing responses. I mean, we haven't done those randomized trials again because the numbers are much lower in kidney cancers, we know. We could do this trial in triple-negative ones because we had support and we had numbers to conduct this trial. But I'm sure this should be a class effect. I mean, when we can get tumor-agnostic approvals, then some real-world data has come up in almost all tumors, we have seen that consistent effect across tumors. And as we speak of today, I'm also delighted to share that in India, yesterday, we had the first biosimilar of nivolumab and that's now available at a much, much lower price than the original patent product. There was a long ongoing lawsuit that was there, that's over now, and from yesterday onwards, I'm so happy to share here that we would have the first biosimilar of nivolumab that's available. That's going to bring the cost to almost like one-tenth already. Dr. Monty Pal: Wow. That's huge. I'm going to be very selfish here for a second and focus on a study that is in the renal cell space that your group has done. You know, when it came out, I was really sort of intrigued by this study as well and it reflects sort of a different capability, I think, of AIIMS New Delhi, and that's in the, what I'm going to call, biomarker space. This, for the audience, was a prospective effort to characterize germline variants in patients with advanced kidney cancer. And it's something that we talk about a lot in the kidney cancer literature, whether or not we're missing a lot of these so-called hereditary patterns of RCC. Can you tell us a little bit about that study too? Dr. Atul Batra: Yeah, so that was led by one of our fellows, Chitrakshi Nagpal, and she's just completed her fellowship. And two years back we published that. So, that was done in almost 160 consecutive patients that we recruited over the span of just one year and we saw, apart from the common known mutations in RCC, that was around 5% or so, but a lot of other mutations were also seen that we don't generally see in kidney cancers and we see in other cancers like BRCA1, BRCA2 and others. We are still, I mean, doing those analyses to see whether we get more things out of there in the somatic: is there a loss of heterozygosity or was it just present and in there? Dr. Monty Pal: I thought it was a terrific study and again, I was just so blown away at the pace. I mean, as I look at 140 patients accrued over a span of one year, this is something that would take us perhaps three times as long at City of Hope, and that's with a very sort of, what I consider to be large and dedicated kidney cancer program. So, it really underscores, I think, the need for collaboration. And ever since I came back from my visit to you at AIIMS Delhi, I think I've just been sort of transformed in the sense of trying to think of better ways for us to collaborate. One tangible thing that I'm going to get cracking on is seeing whether or not perhaps we can form some partnerships through SWOG or what we call the NCTN, the National Clinical Trials Network here within the U.S. Talk to me about collaboration. I mean, you've been really terrific at this. How do you sort of envision collaboration enhancing the global landscape of oncology? Dr. Atul Batra: That's really amazing, Monty. That's what we need. We have the infrastructure, we have the manpower, we have patients. I mean, these are all high-volume centers. Unfortunately, we are a little less in numbers, so we are more clinically occupied as well. So, sometimes it's kind of tougher, but again, when it comes to helping out the patients, global collaboration, we need to kind of take you guys along with us and have our patients finish trials earlier. This is a win-win situation for patients, one, because they also get exposure or an option to participate in the clinical trials, and second, we can answer all these scientific questions that we have at a much faster pace. All those things can be done within a much shorter span of time for sure. We are so happy to hear that, and with open hands we are ready to collaborate for all these efforts. Dr. Monty Pal: That's awesome. You know, I came back thinking, gosh, this would be so ideal for some of these rare subtypes of kidney cancer. Prospective clinical trials that I'm running in that space where really we're threatened with closure all the time. And if we just sort of extended a hand to, you know, our partners in India and other countries, you know, I'm sure we could get this research done in a meaningful way and that's got to be a win for patients. Atul, I had such a terrific time chatting with you today. I'm looking forward to seeing lots more productivity from your group there. By the way, for our viewership here, take a look and see what AIIMS New Delhi is doing under the leadership of Dr. Batra and others. It is just a real powerhouse and I think that after doing so, you'll be enticed to collaborate as well. I'm hoping this is the first of many times that we have you on the podcast. Thank you so much for joining. Dr. Atul Batra: Thank you so much for having me here, Monty. It was a pleasure as always speaking to you. And thank you again. Dr. Monty Pal: You got it. Well, and thanks to our listeners. I encourage you to check out Dr. Batra's paper. We'll actually have a link to the study in the transcript of this episode. Finally, if you value the insights that you heard today on the ASCO Daily News Podcast, please rate, review, and subscribe wherever you get your podcasts. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. More on today's speakers: Dr. Monty Pal @montypal Dr. Atul Batra @batraatulonc Follow ASCO on social media: ASCO on X ASCO on Bluesky ASCO on Facebook ASCO on LinkedIn Disclosures: Dr. Monty Pal: Speakers' Bureau: MJH Life Sciences, IntrisiQ, Peerview Research Funding (Inst.): Exelixis, Merck, Osel, Genentech, Crispr Therapeutics, Adicet Bio, ArsenalBio, Xencor, Miyarsian Pharmaceutical Travel, Accommodations, Expenses: Crispr Therapeutics, Ipsen, Exelixis Dr. Atul Batra: Stock and Other Ownership Interests: Zydus Pharmaceuticals, Glenmark, Caplin Point Laboratories, Laurus Research Funding: AstraZeneca, Astellas Pharma, Alkem Laboratories
Send us a textThere are moments in life when you realize — very clearly — who and what is holding you up. This week, I found myself thinking deeply about the people who show up quietly, consistently, and without needing anything in return. And it made me reflect on how much of what weighs us down isn't physical at all — it's emotional, and relational.This episode is an invitation to look at relationships differently. Not through the lens of fixing, forcing, or holding on tighter — but through honesty, acceptance, and relief. If you've ever felt exhausted by relationships, confused by love, or curious about what truly helps us feel lighter — this one is for you.References1. Waldinger, R. J., & Schulz, M. S. (2010). What makes a good life? Lessons from the longest study on happiness. Harvard Study of Adult Development, Harvard Medical School.2. Waldinger, R. J. (2015). What makes a good life? Lessons from the longest study on happiness. TED Talk. Harvard University.3. Holt-Lunstad, J., Smith, T. B., Baker, M., Harris, T., & Stephenson, D. (2015). Loneliness and social isolation as risk factors for mortality: A meta-analytic review. Perspectives on Psychological Science, 10(2), 227–237.4. Gottman, J. M., & Levenson, R. W. (2000). The timing of divorce: Predicting when a couple will divorce over a 14-year period. Journal of Marriage and Family, 62(3), 737–745.5. Beck, J. S. (2011). Cognitive behavior therapy: Basics and beyond (2nd ed.). Guilford Press.6. Gross, J. J. (2015). Emotion regulation: Current status and future prospects. Psychological Inquiry, 26(1), 1–26.Let's go, let's get it done. Get more information at: http://projectweightloss.org
In this episode, I sit down with one of my former mentors and professors, Dr. Alan Penzias, Medical Director at Boston IVF and Associate Professor at Harvard Medical School, to discuss his recent editorial in the Annals of Internal Medicine titled "The Weighty Issue of Obesity and Reproductive Success." Read the full show notes on Dr. Aimee's website. We dive deep into how age and weight factor into the fertility equation and why these conversations are so critical for anyone trying to conceive. Dr. Penzias shares his decades of experience helping patients navigate the complex intersection of body mass index, maternal age, and reproductive success, offering practical guidance on when to seek treatment and how to optimize your health before trying to get pregnant. In this episode, we cover: How age remains the strongest predictor of fertility success and why both partners should consider timing The U-shaped curve of BMI and fertility: why both low and high body mass index can impact conception Practical strategies for doctors for discussing weight and fertility with patients in a shame-free, empowering way When to prioritize immediate fertility treatment versus taking time for weight optimization based on age The role of GLP-1 medications (like Tirzepatide) in fertility treatment and safe protocols for use Why unexplained infertility may have hidden explanations related to weight and metabolic health The "do the as if" philosophy: building sustainable health habits one step at a time Resources: Dr. Alan Penzias and Boston IVF: BostonIVF.com Dr. Penzias's editorial: "The Weighty Issue of Obesity and Reproductive Success" - Annals of Internal Medicine https://www.acpjournals.org/doi/10.7326/ANNALS-25-02742 Dr. Penzias's YouTube video: "Evidence-Based Approach to Unexplained Infertility" https://youtu.be/9j4lNvmaXts?si=zmMFZFOno0sWnhcn American Society for Reproductive Medicine (ASRM) Practice Committee resources on overweight and fertility https://www.asrm.org/ Dr. Stephanie Fein - Fertility Weight Loss Specialist: https://www.stephaniefeinmd.com/ Hillary Wright, Nutritionist at Boston IVF: https://www.bostonivf.com/physicians/hillary-wright Do you have questions about IVF?Click here to join Dr. Aimee for The IVF Class. The next live class call is on Monday, February 9, 2026 at 4pm PST, where Dr. Aimee will explain IVF and there will be time to ask her your questions live on Zoom. Dr. Aimee Eyvazzadeh is one of America's most well known fertility doctors. Her success rate at baby-making is what gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org. Other ways to connect with Dr. Aimee and The Egg Whisperer Show: Subscribe to my YouTube channel for more fertility tips!Subscribe to the newsletter to get updates
In this episode of The MSing Link Podcast, I'm thrilled to welcome Dr. Kelly Rich, neuroscientist at Harvard Medical School, for a deep dive into how multiple sclerosis (MS) might accelerate brain aging—and what the latest research reveals. We explore the connection between MS, cellular aging, and innovative new therapies like cellular reprogramming that could help protect and rejuvenate your nervous system. Dr. Rich shares practical insights on supporting brain health, resilience, and ways to slow neurological decline. Whether you're looking to reduce MS fatigue, improve mobility, or boost your cognition, this episode is packed with expert advice, empowering exercises, and actionable tools for living better with MS. Tune in for an inspiring discussion on MS treatments, neuroscience, anti-inflammatory strategies, and hope for future breakthroughs in MS care! About Dr. Kelly Rich: Dr. Kelly Rich, a neuroscientist and clinical genetic counselor at Harvard Medical School, who works in Dr. David Sinclair's lab studying how aging affects our nervous system at the cellular level. Connect with Dr. Kelly Rich:Instagram: https://www.instagram.com/kellyrichphd Connect with the Sinclair Lab:Instagram: https://www.instagram.com/sinclair_labWebsite: https://sinclair.hms.harvard.edu/?utm_source=ig&utm_medium=social&utm_content=link_in_bio&fbclid=PAZXh0bgNhZW0CMTEAc3J0YwZhcHBfaWQMMjU2MjgxMDQwNTU4AAGnPtOlP1oSYiX1wyDKp-8TxE5-kbY81__aH1AWVU_qn2JJGn-dihYq4uHn6Wg_aem_7n-6t_jlL2A68qgb0q7bVALifespan with Dr. David Sinclair Podcast: https://podcasts.apple.com/us/podcast/lifespan-with-dr-david-sinclair/id1601709306 Additional Resources: https://www.doctorgretchenhawley.com/insider Reach out to Me: hello@doctorgretchenhawley.com Website: www.MSingLink.com Social: ★ Facebook: https://www.facebook.com/groups/mswellness ★ Instagram: https://www.instagram.com/doctor.gretchen ★ YouTube: https://www.youtube.com/c/doctorgretchenhawley?sub_confirmation=1 → Game Changers Course: https://www.doctorgretchenhawley.com/GameChangersCourse → Total Core Program: https://www.doctorgretchenhawley.com/TotalCoreProgram → The MSing Link: https://www.doctorgretchenhawley.com/TheMSingLink
Send us a textFebruary is National Heart Month, and in the month of hearts, we're revisiting one of the most important conversations from the Ageless Glamour Girls™ Podcast archives.Broken Heart Syndrome can mimic the symptoms of a heart attack - and it can occur after sudden, intense emotional or physical stress. Research shows cases are increasing, particularly among middle-aged and older women. This episode originally aired during our debut season in March 2022, but its message feels even more urgent today. We're joined by Dr. Susan Cheng, senior author of a major study on the condition and a leading cardiologist at the Smidt Heart Institute at Cedars-Sinai. Dr. Cheng breaks down:What Broken Heart Syndrome is - and what it isn'tWhy women are disproportionately affectedThe powerful role stress plays in heart healthAnd, most importantly, why this condition is treatableIf you've ever felt the physical weight of emotional stress, this conversation matters. And here's to Healthy Aging and Joyful Living, Luvvies!**********************GUEST BIO: Susan Cheng, MD, MMSc, MPH is the Erika J. Glazer Chair in Cardiovascular Health and Population Science, Director of the Institute for Research on Healthy Aging, and Director of Population Health Sciences at the Smidt Heart Institute at Cedars-Sinai. She also serves as Professor and Vice Chair of Research Affairs in the Department of Cardiology. Dr. Cheng is a cardiologist, echocardiographer, and clinician-scientist who leads nationally recognized research programs focused on the drivers of cardiovascular aging in women and men. She received her bachelor's degree from Harvard College, her medical degree from McMaster University, a Master of Medical Science from MIT, and a Master of Public Health from Harvard.She completed internal medicine training at The Johns Hopkins Hospital and cardiology training at Brigham and Women's Hospital and Harvard Medical School, where she later served as cardiology faculty and Associate Director of the Cardiovascular Imaging Core Laboratory. Dr. Cheng is also Co-Director of the Framingham Heart Study Echocardiography Laboratory and Co-Director of the international Bioactive LipidsNet Consortium. She has served on editorial boards of major cardiovascular and imaging journals and on leadership committees for the American Heart Association and the American College of Cardiology. Dr. Cheng has chaired and contributed to multiple American Heart Association scientific statements on research methods, heart disease statistics, and cardiovascular care of older adults. She has authored more than 4Support the show https://buymeacoffee.com/agelessglamourgirls www.linkedin.com/in/marqueetacurtishaynes www.agelessglamourgirls.com https://www.shopltk.com/explore/AgelessGlamourGirls https://www.youtube.com/@agelessglamourgirls Instagram @agelessglamourgirls Facebook: https://www.facebook.com/agelessglamourgirls Private (AGG) FB Group: The Ageless Café: https://www.facebook.com/groups/theagelesscafe TikTok: @agelessglamourgirls Podcast Producers: Ageless Glamour Girls and Purple Tulip Media, LLC
Send us a textHow deep into AI do clinicians really need to go? In this clip from our episode "Making Healthcare Massively Better", CareTalk host John Driscoll speaks with Halle Tecco about why becoming AI-literate is the only way to build real guardrails as patients use tools like ChatGPT at scale.Listen to the full episode here
“My times were dropping and it was so exciting. Every week, they were dropping, dropping, dropping. It was pretty early in the season, too. At that point, I hadn't even made NCAAs. At the time when I ran 2:00, I had the number one time in the country. There was a lot that happened super fast… I think that was my favorite race of my life. I never even thought in my mind that I could run 2:00 even earlier on in the season. It broadened the horizons of what I think I'm capable of in the future and to never limit myself.”My guest for today's episode is Victoria Bossong. This week on the podcast, CITIUS MAG is bringing you interviews with some of Team New Balance's latest signees as we celebrate five years of partnering with them on all things from the high school to the professional front. Yesterday, we brought you an interview with Roisin Willis and now we've got another strong rising 800m runner.Victoria was a star high school sprinter in Maine who almost on a whim tried the 800m late into her prep career and found success. Fast forward a few years and she's fully committed to the event. In 2025 while at Harvard, she was the NCAA Indoor Championships runner-up and ran an outdoor personal best of 1:59.48. She just opened up her indoor season as a pro with an indoor 1000m PB of 2:36. Off the track, she's just as impressive. She has her degree in neuroscience and has worked in a Harvard Medical School lab. In our chat, she discusses how she managed to balance all of that as a student-athlete, how she comes at the 800m from more of a sprinter background, and her goals for her first professional season.____________Host: Chris Chavez | @chris_j_chavez on InstagramGuest: Victoria Bossong | @victoriabossong on InstagramProduced by: Jasmine Fehr | @jasminefehr on Instagram____________SUPPORT OUR SPONSORSUSATF: The USATF Indoor Track and Field Championships presented by Prevagen are back in New York City from February 28th to March 1st at the Ocean Breeze Athletic Complex in Staten Island. This is where legends don't just race; they punch their ticket to the world stage. The pressure is real, the margins are razor thin, and every athlete is fighting for one thing: a spot on Team USATF at the World Indoor Championships. Grab your tickets now at USATF.org/tickets and experience track and field at its absolute loudest.OLIPOP: A blast from the past, Olipop's Shirley Temple combines smooth vanilla flavor with bright lemon and lime, finished with cherry juice for that nostalgic grenadine-like flavor. One sip of this timeless soda proves some flavors never grow old. Try Shirley Temple and more of Olipop's flavors at DrinkOlipop.com and use code CITIUS25 at checkout to get 25% off your orders.
Ewa Grassin jest naukowczynią na Harvard Medical School. W swojej pracy tworzy modele ludzkiego mózgu z komórek macierzystych, by lepiej zrozumieć choroby neurologiczne. W odcinku nauka jest jednak tylko punktem wyjścia. To rozmowa o tym, jak naprawdę wygląda kariera naukowa w Stanach Zjednoczonych: o drodze do pracy w jednym z najbardziej konkurencyjnych środowisk na świecie, presji grantów, zawodowej niepewności, statusie imigracyjnym i codzienności, która ma niewiele wspólnego z filmowym wyobrażeniem Harvardu.
I had the absolute pleasure of sitting down with Dr. Amy Comander on The Breast Cancer Podcast
I am so happy to welcome Dr. Ellen Braaten back for her third time on the show! In case you missed those episodes and/or need a refresher, Dr. Ellen Braaten is the founding director of the Learning and Emotional Assessment Program at Massachusetts General Hospital and an associate professor at Harvard Medical School. She is a prolific researcher and author whose work focuses on ADHD, learning disorders, child psychopathology, processing speed, intelligence, and children's motivation, including bestselling books for parents and professionals. Deeply committed to public education, she frequently speaks on child mental health topics and contributes to both local and national media. In our conversation, we talk about why unmotivated kids rarely fit neatly into a single category, with Dr. Braaten explaining that children may struggle with motivation for a variety of reasons, such as cognitive overload, emotional fatigue, repeated failure, or even a lack of clear identity. She also explains why framing these challenges as brain-based skills, rather than personal failings, can help change the way parents and clinicians respond. We also discuss the narrowing of opportunities in schools today, why kids need space to discover their own strengths beyond academics and athletics, and how uncomfortable emotions such as shame, anxiety, or regret can silently block motivation. Dr. Braaten's workbook is designed not just for children but for the adults supporting them, and she shares how parents, teachers, and therapists can use its activities to spark meaningful conversations, assess where a child gets stuck, and offer guidance without shame. It's about collaboration, not enforcement, and about helping kids take ownership of their growth while navigating setbacks safely. This episode of the show will surely resonate with anyone supporting tweens and teens, whether you're a parent, educator, or clinician, and offers strategies to help young people (and even adults) rediscover what matters to them, reclaim their motivation, and move forward with confidence! Show Notes: [2:09] - Hear how Dr. Ellen Braaten realized poor motivation affects everyone, especially during stressful, sleep-deprived times. [5:40] - Motivation consists of initiation, persistence, and desire, and can be treated as a learnable skill. [7:56] - Dr. Braaten discusses how kids today struggle to find identity due to overwhelming choices and early specialization pressures. [9:52] - Dr. Braaten argues that strengths extend beyond academics and sports, yet schools rarely provide opportunities to explore diverse talents. [11:51] - Hear how setbacks, injuries, or missed guidance can lead to regret. [13:44] - Breaking motivation into initiation, intensity, and persistence can help kids, parents, and clinicians clarify obstacles. [16:28] - Dr. Braaten points out how even small changes, like better sleep, improve motivation. [18:04] - Parents should balance support and independence, empowering children while preventing guilt or overwhelming hovering. [21:18] - Anxiety and post-pandemic habits have reduced face-to-face engagement, creating cycles that undermine motivation. [23:04] - Dr. Braaten's workbook is best used with adults as guides, sparking conversations about identity and priorities. [26:05] - Hear how to contact Dr. Braaten. Links and Related Resources: Episode 61: Slow Processing Speed with Dr. Ellen Braaten Episode 107: How to Motivate Kids Who Couldn't Care Less with Dr. Ellen Braaten Dr. Ellen Braaten & Hillary Bush - The Motivation Mindset Workbook: Helping Teens and Tweens Discover What They Love to Do Connect with Dr. Ellen Braaten: Dr. Ellen Braaten's Website
Most people never escape the circumstances they're born into — Dr. Ming Wang escaped Communist China with $50 and went on to restore sight to millions. In this episode of The Root of All Success, Jason Duncan sits down with Dr. Ming Wang, a Harvard- and MIT-trained physician, laser eye surgeon, and the inventor who donated a multi-million dollar patent to help blind children worldwide. Dr. Wang breaks down how he redefined success from outcomes to effort, why he chose purpose over profit, and how perseverance rooted in faith carried him from darkness to light — both literally and spiritually. This conversation dives into: Why he completed three years of high school in weeks to escape labor camps How earning both an MD and a PhD made him a one-of-a-kind surgeon The moment he chose to donate his invention instead of cashing in Why success should be measured by effort, not results How his conversion from atheism to Christianity transformed his purpose The business lesson medical school never taught him about serving your audience first If you're facing impossible odds, searching for deeper purpose in your work, or need to redefine what success means to you — this episode will challenge everything you thought you knew about achievement.
Send us a textIn this episode, Dr. Amy Gelfand, a child neurologist specializing in pediatric headaches, discusses the complexities and treatment of migraines in children. Gelfand explains the genetic nature of migraines and their commonality among kids, noting triggers like menstrual cycles and changes in sleep patterns. She elaborates on distinguishing features of migraines and provides insight into preventive and acute treatments, including NSAIDs, triptans, neuromodulation devices, and supplements. The discussion also covers the importance of a regular schedule, the benefits of cognitive behavioral therapy (CBT), and recent advancements in migraine-specific medications. Dr. Gelfand emphasizes the significant progress in migraine treatment and encourages families to consult specialists for personalized care.About Dr Gelfand:Dr. Amy Gelfand is a pediatric neurologist who specializes in diagnosing and treating children with a variety of headache disorders, as well as those with childhood periodic syndromes (such as abdominal migraine), which may be precursors to migraine headache later in life. Her research focuses on the epidemiology of pediatric migraine and childhood periodic syndromes.Gelfand received her medical degree from Harvard Medical School. She completed residencies in pediatrics and child neurology at UCSF.Gelfand has received a teaching award from the UCSF pediatric residency program and writing awards from the medical journal Neurology. She is a member of the American Academy of Neurology, Child Neurology Society and American Headache Society.Your Child is Normal is the trusted podcast for parents, pediatricians, and child health experts who want smart, nuanced conversations about raising healthy, resilient kids. Hosted by Dr. Jessica Hochman — a board-certified practicing pediatrician — the show combines evidence-based medicine, expert interviews, and real-world parenting advice to help listeners navigate everything from sleep struggles to mental health, nutrition, screen time, and more. Follow Dr Jessica Hochman:Instagram: @AskDrJessica and Tiktok @askdrjessicaYouTube channel: Ask Dr Jessica If you are interested in placing an ad on Your Child Is Normal click here or fill out our interest form.-For a plant-based, USDA Organic certified vitamin supplement, check out : Llama Naturals Vitamin and use discount code: DRJESSICA20-To test your child's microbiome and get recommendations, check out: Tiny Health using code: DRJESSICA The information presented in Ask Dr Jessica is for general educational purposes only. She does not diagnose medical conditi...
Andrew Beck, MD, PhD is the Co-founder and CEO of PathAI, where he and his team are developing AI tools to improve the precision of pathology and the efficacy of drug development for diagnosis of cancer and also many other complex diseases.Before founding PathAI, Andrew was an Associate Professor at Harvard Medical School, where his research focused on the application of machine learning to cancer pathology. He earned his MD from Brown University and his PhD in Biomedical Informatics from Stanford University, where he pioneered some of the first computational models used to predict patient outcomes in oncology.Time stamps of the conversation:00:00:00 Highlights00:01:28 Introduction00:02:18 Entrypoint in AI00:07:02 Background in Medicine and Bioinformatics 00:10:00 Leap from academia to entrepreneurship00:16:20 Translating AI developments to Pathology00:21:15 Specialist vs Generalist AI models in medicine00:24:15 What sets PathAI apart?00:26:32 AI adoption medicine00:34:25 Usage of AI tools in clinical workflows, example MASH00:40:10 AI in Dermatopathology00:42:15 AI for biomarker discovery00:47:05 Will AI models replace pathologists?00:52:28 Avoiding over-reliance on AI00:57:40 Is AI living unto the hype?01:01:00 Challenges in clinical trials 01:05:12 AI reaching patients directly01:09:50 Working at intersection of AI & Healthcare01:15:30 Pitfalls to learn fromMore about PathAI: https://www.pathai.com/and Andy: https://www.pathai.com/about-us/andy-beckAbout the Host:Jay is a Machine Learning Engineer III at PathAI working on improving AI for medical diagnosis and prognosis. Linkedin: https://www.linkedin.com/in/shahjay22/Twitter: https://twitter.com/jaygshah22Homepage: https://jaygshah.github.io/ for any queries.Stay tuned for upcoming webinars!***Disclaimer: The information in this video represents the views and opinions of the speaker and does not necessarily represent the views or opinions of any institution. It does not constitute an endorsement by any Institution or its affiliates of such video content.***
In this episode of The ICHE Podcast, host Dr. David Calfee explores non–ventilator-associated hospital-acquired pneumonia (NV-HAP)—what it is, how common it is, and why it matters for patient outcomes. He is joined by Dr. Barbara Jones (University of Utah) and Dr. Sheryl Kluberg (Harvard Pilgrim Health Care Institute and Harvard Medical School) to discuss key risk factors for NV-HAP and how preventable it may be. The conversation highlights practical prevention strategies, including the role of routine oral care and patient mobility. Dr. Jones shares insights from her ICHE study evaluating the impact of an oral care initiative using electronic clinical data and diagnostic coding, while Dr. Kluberg discusses her research on the associations between oral care, in-hospital mobility, and NV-HAP. Together, they break down the study questions, methods, key findings, and real-world implications for infection prevention efforts. This episode offers a concise, evidence-based look at how everyday care practices can help reduce the burden of NV-HAP in hospitalized patients. Links: Jones, Barbara E., Alec B. Chapman, Jian Ying, McKenna R. Nevers, Shannon Munro, Michael Klompas, Amy L. Valderrama, and Daniel O. Scharfstein. “Evaluating the Impact of an Oral Care Initiative on the Risk of Non-Ventilator-Associated Hospital-Acquired Pneumonia Using Electronic Clinical Data and Diagnostic Coding Surveillance Criteria.” Infection Control & Hospital Epidemiology 46, no. 12 (2025): 1190–98. https://doi.org/10.1017/ice.2025.54. Kluberg, Sheryl A., Tom Chen, Rui Wang, Robert Jin, Laura DelloStritto, Dian Baker, Karen Giuliano, et al. “Associations between Routine Oral Care and In-Hospital Mobility with Non-Ventilator Hospital-Acquired Pneumonia.” Infection Control & Hospital Epidemiology 46, no. 12 (2025): 1181–89. https://doi.org/10.1017/ice.2025.10245.
Send us a textHealthcare innovation has never had more hype or more pressure to deliver real results. With AI accelerating and digital health entering a more mature phase, what does “better” actually look like in practice? Halle Tecco, Author of Massively Better Healthcare joins CareTalk host John Driscoll, Chairman of UConn Health, to discuss what Silicon Valley gets right and wrong about healthcare, why innovators need to align incentives with outcomes, and how leaders should think about AI with clear guardrails instead of buzzwords.
From Discovery to Delivery: Charting Progress in Gynecologic Oncology, hosted by Ursula A. Matulonis, MD, brings expert insights into the most recent breakthroughs, evolving standards, and emerging therapies across gynecologic cancers. Dr Matulonis is chief of the Division of Gynecologic Oncology and the Brock-Wilcon Family Chair at the Dana-Farber Cancer Institute, as well as a professor of medicine at Harvard Medical School, both in Boston, Massachusetts.In this episode, Dr Matulonis sat down with guest Rebecca Porter, MD, PhD. Dr Porter is a physician at Dana-Farber Cancer Institute and an assistant professor of medicine at Harvard Medical School.Drs Matulonis and Porter discussed the evolving role of immunotherapy in gynecologic cancer management, focusing on recent clinical breakthroughs and future directions. They noted that although high-grade serous ovarian cancer has historically been refractory to immunotherapy, the phase 3 KEYNOTE-B96 trial (NCT05116189) demonstrated an efficacy benefit with the addition of pembrolizumab to weekly paclitaxel for patients with platinum-resistant disease. In particular, improvements in overall survival were noted in the PD-L1–positive patient population. Dr Porter attributed this success to the metronomic weekly dosing of paclitaxel, which may increase neoantigen levels and favorably alter the tumor microenvironment (TME).Moreover, the experts highlighted how immunotherapy has already become the standard of care for patients with mismatch repair–deficient advanced or recurrent endometrial cancer. However, they explained that for the mismatch repair–proficient population, this benefit is less clear and appears most significant in patients with measurable disease or specific molecular subtypes. They added that although circulating tumor DNA (ctDNA) assay results correlate with treatment outcomes, ctDNA is currently not an actionable biomarker for determining treatment duration or selection.Lastly, Drs Matulonis and Porter reported that the field of gynecologic oncology is shifting toward combination therapies and novel platforms beyond standard checkpoint inhibitors. Treatment advances include bispecific and trispecific antibodies that engage multiple cell types or signals; as well as adoptive cellular therapies, such as CAR T-cell and CAR natural killer–cell therapies. Ultimately, the experts concluded that the goal of managing challenging-to-treat diseases like ovarian cancer is to use combinatorial approaches—incorporating vaccines, anti-angiogenic therapies, and chemotherapy—to overcome the immunosuppressive nature of the TME.
Dr Haley Ellis from Harvard Medical School in Boston, Massachusetts, Prof Eric Van Cutsem from University Hospitals Leuven in Belgium, Dr Zev Wainberg from UCLA School of Medicine in Los Angeles, California, and moderator Dr Lionel KankeuFonkoua from Mayo Clinic in Rochester, Minnesota, discuss recent data surrounding the management of HER2-positive GI cancers, alongside their perspectives on its clinical application and management.CME information and select publications here.
FOR en gjest i ukas episode av Nerdelandslaget!
Dr Haley Ellis from Harvard Medical School in Boston, Massachusetts, Prof Eric Van Cutsem from University Hospitals Leuven in Belgium, Dr Zev Wainberg from UCLA School of Medicine in Los Angeles, California, and moderator Dr Lionel KankeuFonkoua from Mayo Clinic in Rochester, Minnesota, discuss recent data surrounding the management of HER2-positive GI cancers, alongside their perspectives on its clinical application and management.CME information and select publications here.
Most medical encounters are structured as transactions. The patient comes in with a specific complaint, the medical expert identifies a discrete problem, and a specific intervention is prescribed.But at the heart of a medical encounter is a story. When a patient comes in with a medical problem, the problem cannot be disentangled from their life's narrative — doing so risks hollowing out the essence of what it means to care for another person. Our guest on this episode is award-winning author, and primary care physician Suzanne Koven, MD. Following the completion of her residency at Johns Hopkins Hospital, Dr. Koven joined the faculty at Harvard Medical School and practiced primary care medicine at Massachusetts General for 32 years. In 2019, she became the inaugural Writer in Residence at Mass General. Her writings have been published broadly—including in The Boston Globe, The New England Journal of Medicine, The Lancet, and The New Yorker. As a teacher and public speaker, she highlights the relationship between literature and medicine, and is a powerful advocate for female medical trainees. In this episode, Dr. Koven shares her journey to medicine at a time when few women were represented in the field and why she finds her undergraduate English classes to be more relevant to her clinical work than her science classes. We discuss narrative medicine, its value to patients and physicians alike, and how the modern healthcare system struggles to value the patient story. Finally, Dr. Koven leaves us with her advice for up-and-coming trainees: find a place in medicine where you can be yourself – for your own good and for your patients'.In this episode, you'll hear about: 3:00 - Dr. Koven's motivations for going into primary care medicine 15:49 - The impact that Dr. Koven's English degree has had on her approach to medicine 19:36 - What narrative medicine is 24:34 - What is lost when human connection and human story are deprioritized within the practice of medicine 31:15 - The benefits doctors experience when cultivating an appreciation for the arts37:21 - How gender representation in medicine has shaped Dr. Koven's experience as a physician42:54 - The need for the culture of medicine to adapt to changing demographics in the medical workforceIf you enjoyed this episode, please subscribe, rate, and review our show, available for free on Spotify, Apple Podcasts, or wherever you get your podcasts. If you know of a doctor, patient, or anyone working in health care who would love to explore meaning in medicine with us on the show, feel free to leave a suggestion in the comments or send an email to info@thedoctorsart.com.Copyright The Doctor's Art Podcast 2026
Cassandra Bodzak is a spiritual teacher, holistic wellness coach, and actress known for helping soul-led women design lives that support their energy, purpose, and expansion. Through her signature Sacred Structure method, an intuitive blend of astrology, human design, and ritualized scheduling, she guides others to craft daily rhythms that nourish the body, regulate the nervous system, and amplify creative power. Cassandra studied Lifestyle Medicine and Nutrition and Wellness Coaching through Harvard Medical School and is certified as a HHC through the Institute of Integrative Nutrition. Her approach bridges science and spirit, grounding metaphysical tools in sustainable, embodied practices. You may have seen her on ABC's The Taste with Anthony Bourdain as the “happy, healthy living guru,” or featured in collaborations with SHAPE, Teen Vogue, Eating Well, Huffington Post, Thrive, Fabletics, Lululemon, and SoulCycle. In This Episode, We Explore:Cassandra's full-circle journey of revamping her first book and evolving authenticallyHow her brother's illness inspired her passion for nutrition, cooking, and healingLearning to trust body wisdom through intuitive eating and becoming a “food detective”Navigating postpartum nutrition, cravings, and conflicting health advice with clarityWhy quality ingredients, education, and gratitude matter more than rigid food rulesFollow Cassandra on Instagram: http://instagram.com/cassandrabodzak Follow Cassandra on Substack: https://substack.com/@cassandrabodzak Listen to Cassandra on her podcast, YOU with Intention by Cassandra Bodzak: https://podcasts.apple.com/us/podcast/you-with-intention-by-cassandra-bodzak/id1042765691 Pre-Order Cassandra's Book, The Mindful Table: Recipes & Affirmations for Intuitive, Seasonal Eating: https://a.co/d/gC64CQ0 Read all of Cassandra books here: https://amzn.to/46KjTUV Stay Connected:Instagram @whitneyaronoffInstagram @starseedkitchenTikTok @whitneyaronoffTikTok @starseedkitchenLearn more about Starseed Kitchenwww.starseedkitchen.comShop organic spiceshttps://starseedkitchen.com/shop/code STARSEED for 10% offWork with a personal chefhttps://form.typeform.com/to/CGDu08tEBook a 1-on-1 callhttps://bit.ly/4smXWUfFind more of Chef Whitney's offerings herehttps://linktr.ee/whitney.aronoff
Some families are living on an emotional rollercoaster. One minute everyone seems fine. The next, it feels like the wheels are coming off. In this episode of Complicated Kids, I sit down with Dr. Kate Lund, a licensed clinical psychologist, resilience expert, and twin mom, to talk about resilience as a way of living rather than a trait you either have or do not have. Instead of seeing resilience as "you hit a challenge and bounce back," we explore what it looks like to build a steadier baseline so you can ride the waves of real life with a little more ease. Dr. Kate shares how she helps parents understand their own context first. That includes their nervous system, history, strengths, and the particular stressors they are carrying. From there, we talk about practical tools for modulating your stress response, including a simple daily relaxation practice that helps you learn what "regulated" actually feels like in your body so you can return to it more often. We also talk about timing. Kids of all ages need space to feel their feelings before they can look for possibilities or "what's next." We walk through real-life examples, including college rejections, tough games, and everyday disappointments, and how to sit with your child's emotions without rushing to fix them. A big part of this conversation focuses on perfectionism and comparison. Dr. Kate and I discuss why there is no resilience formula, why siblings in the same family can need completely different things, and how to move away from "perfect outcome" thinking and toward doing what is optimized within your own context. If you've ever wondered how to be a grounded leader in your family while still being a real human with your own feelings and limits, this episode will give you language, tools, and a more compassionate way to think about resilience for both you and your kids. Key Takeaways Resilience is a lifestyle, not a moment. Regulation becomes more accessible when tools are woven into daily life instead of saved for crises. Your nervous system sets the tone. When you are already stressed, even small challenges can overwhelm the whole family. A simple daily practice matters. A five-minute breathing practice paired with a calming word can teach your body what calm feels like. Self-awareness comes before strategy. Resilient parenting starts with being honest about your own strengths, limits, and stress patterns. Every child has their own context. Siblings can need completely different support based on their nervous systems. Validation comes before possibility. Kids need their feelings acknowledged before they can move forward. Sharing struggles builds connection. Age-appropriate honesty shows kids that resilience includes falling down and getting back up. Perfectionism blocks resilience. Growth happens when you work within your real life, not an imaginary ideal. There is no one-size-fits-all formula. Resilient families stay curious and adjust over time. Possibility lives on the other side of hard things. Holding a long view allows hope without minimizing today's challenges. About Dr. Kate Lund Dr. Kate Lund is a licensed clinical psychologist, resilience expert, author, and host of The Optimized Mind podcast. With specialized training from three Harvard Medical School–affiliated hospitals and more than two decades of clinical practice, she helps parents, athletes, students, and entrepreneurs thrive within their unique contexts. She is the author of Bounce: Help Your Child Build Resilience and Thrive in School, Sports, and Life and Step Away: The Keys to Resilient Parenting. Dr. Kate also volunteers at Seattle Children's Hospital with her dog, Wally, supporting young patients facing medical challenges. About Your Host, Gabriele Nicolet I'm Gabriele Nicolet—toddler whisperer, speech therapist, parenting life coach, and host of Complicated Kids. Each week, I share practical, relationship-based strategies for raising kids with big feelings, big needs, and beautifully different brains. My goal is to help families move from surviving to thriving by building connection, confidence, and clarity at home. Complicated Kids Resources and Links
Janina Fisher, Ph.D. is a licensed clinical psychologist and a former instructor at Harvard Medical School.She is an international expert on the treatment of trauma and an Advisory Board member of the Trauma Research Foundation as well as the author of three books, including her most recent, Embracing Our Fragmented Selves: A Workbook for Trauma Survivors and TherapistsHealing the Fragmented Selves of Trauma Survivors: Overcoming Self-Alienation (2017), Transforming the Living Legacy of Trauma: a Workbook for Survivors and Therapists (2021), and The Living Legacy Instructional Flip Chart (2022). Janina is best known as the creator and trainer of Trauma-Informed Stabilization Treatment (TIST), a parts approach to resolution and healing.In This EpisodeJanina's websiteJanina's books:Healing the Fragmented Selves of Trauma Survivors: Overcoming Self-Alienation (2017)Transforming the Living Legacy of Trauma: a Workbook for Survivors and Therapists (2021)The Living Legacy Instructional Flip Chart (2022). Become a supporter of this podcast: https://www.spreaker.com/podcast/the-trauma-therapist--5739761/support.You can learn more about what I do here:The Trauma Therapist Newsletter: celebrates the people and voices in the mental health profession. And it's free! Check it out here: https://bit.ly/4jGBeSa———If you'd like to support The Trauma Therapist Podcast and the work I do you can do that here with a monthly donation of $5, $7, or $10: Donate to The Trauma Therapist Podcast.Click here to join my email list and receive podcast updates and other news.Thank you to our Sponsors:Jane App - use code GUY1MO at https://jane.appArizona Trauma Institute at https://aztrauma.org/
Jordan Amadio, M.D., is a board-certified neurosurgeon, and his clinical practice focuses on minimally invasive spine surgery, surgical neuro-oncology and neurotrauma. Amadio received his medical education at Harvard Medical School and the Massachusetts Institute of Technology before completing a neurosurgery residency at Emory University. At Emory, he pursued research fellowships as a Council of State Neurosurgical Societies socioeconomic fellow and a Congress of Neurological Surgeons innovation fellow. He also earned an MBA from Harvard Business School, with emphasis on medical technology innovation. As affiliated faculty and a National Institutes of Health-funded investigator within Texas Robotics, he works with robotics experts to build next-generation tools and implants for spine surgery. Previously, he co-founded the NeuroLaunch incubator for neurotechnology startups and has since advised dozens of medical technology ventures. Outside his academic work, Amadio is closely involved with the development of brain-computer interface technology as a director of neurosurgery at Neuralink. Amadio is deeply committed to mentoring the next generation of physicians and enjoys teaching students and residents. As a way of giving back, he has also been active in providing neurosurgical care to socioeconomically challenged populations, from Texas to Mirebalais, Haiti.Support the show
Get the book, The Digital Delusion: How Classroom Technology Harms Our Kids' Learning—And How To Help Them Thrive Again Visit the LME Global website, www.LMEGlobal.net Follow Jared on Youtube @JaredCooney About The Author Jared Cooney Horvath, PhD is a neuroscientist educator who has conducted research and lectured at Harvard University, Harvard Medical School, and The University of Melbourne, and over 750 schools on 6 continents. Jared has published 7 books, over 60 research articles, and his work has been featured in popular publications, including The New Yorker, The Atlantic, The Economist, and on the Australian Broadcasting Corporation's science show Catalyst. Jared currently serves as Director of LME Global: a team dedicated to bringing the latest brain and behavioral research to teachers, students, and parents. This episode of Principal Center Radio is sponsored by IXL, the most widely used online learning and teaching platform for K-12. Discover the power of data-driven instruction in your school with IXL—it gives you everything you need to maximize learning, from a comprehensive curriculum to meaningful school-wide data. Visit IXL.com/center to lead your school towards data-driven excellence today.
What Fresh Hell: Laughing in the Face of Motherhood | Parenting Tips From Funny Moms
Margaret talks with clinical psychologist Dr. Meredith Elkins, author of the new book PARENTING ANXIETY, about how anxiety really works—and how parents can stop unintentionally reinforcing it in themselves and their kids. Dr. Elkins, a faculty member at Harvard Medical School and director of the McLean Anxiety Mastery Program, shares insights from her new book Parenting Anxiety: Breaking the Cycle of Worry and Raising Resilient Kids. Together, they unpack why anxiety isn't something to eliminate, how avoidance makes fear stronger, and why modern “intensive parenting” may be increasing anxiety for both parents and children. You'll learn the three key markers that distinguish normal anxiety from an anxiety disorder (interference, distress, and duration), why psychological flexibility is one of the most important skills we can teach kids, and how cognitive behavioral therapy—especially exposure—helps people face fear instead of shrinking from it. This conversation offers practical, compassionate tools for parents who want to support anxious kids without over-accommodating, and for anyone who wants to change their relationship with anxiety itself. Here's where you can find Dr. Elkins: https://www.meredithelkinsphd.com/ @drmeredithelkins on IG and FB LinkedIn Buy PARENTING ANXIETY: https://bookshop.org/a/12099/9780593798812 What Fresh Hell is co-hosted by Amy Wilson and Margaret Ables. We love the sponsors that make this show possible! You can always find all the special deals and codes for all our current sponsors on our website: https://www.whatfreshhellpodcast.com/p/promo-codes/ What Fresh Hell podcast, mom friends, funny moms, parenting advice, parenting experts, parenting tips, mothers, families, parenting skills, parenting strategies, parenting styles, busy moms, self-help for moms, manage kid's behavior, teenager, tween, child development, family activities, family fun, parent child relationship, decluttering, kid-friendly, invisible workload, default parent, parenting anxiety, child anxiety, anxiety in children, anxiety disorders, psychological flexibility, cognitive behavioral therapy, CBT for anxiety, exposure therapy, intensive parenting, mental health for parents, anxiety coping skills, raising resilient kids, parenting mental health, postpartum anxiety, intrusive thoughts, anxiety management, Harvard psychologist, Meredith Elkins, anxiety treatment, family mental health Learn more about your ad choices. Visit podcastchoices.com/adchoices
Today Razib talks to Aneil Mallavarapu, a scientist and technology leader based in Austin, Texas, whose career bridges the fields of biochemistry, systems biology, and software engineering. He earned his doctorate in Biochemistry and Cell Biology from the University of California, and has held academic positions at Harvard Medical School, where he contributed to the Department of Systems Biology and developed the "Little b" programming language. Mallavarapu has transitioned from academic research into the tech and venture capital sectors, co-founding ventures such as Precise.ly and DeepDialog, and currently serving as a Managing Partner at Humain Ventures. He remains active in the scientific community through local initiatives like the Austin Science Network. Most of the conversation centers around Mallavarapu's arguments outlined in his Substack The Case Against Conscious AI - Why AI consciousness is inconsistent with physics. The core of his argument rests on the "Simultaneity Problem" and the "Hard Problem of Physics," which involve non-locality and the memorylessness of artificial intelligence phenomena. Though Mallavarapu believes that artificial intelligence holds great promise, and perhaps even "artificial general intelligence" (AGI) is feasible, he argues that this is a distinct issue from consciousness, which is a property of human minds. Razib also brings up the inverse case: could it be that many organisms that are not particular intelligence, also have consciousness? What does that imply for ethics of practices like eating meat?
In this Harvard Medical School Spotlight, we take a clear-eyed look at HMS beyond the prestige. We discuss what the school emphasizes in training, how its mission and curriculum shape the student experience, and what applicants often misunderstand about competitiveness and fit. This episode helps you think critically about whether Harvard aligns with your goals—not just your résumé. Like the podcast? Schedule a Free Initial Consultation with our team: https://bemo.ac/podbr-BeMoFreeConsult Don't forget to subscribe to our channel and follow us on Facebook, Instagram, and Twitter for more great tips and other useful information! YouTube: https://www.youtube.com/c/BeMoAcademicConsultingInc Facebook: https://www.facebook.com/bemoacademicconsulting Instagram: https://www.instagram.com/bemo_academic_consulting/ Twitter: https://twitter.com/BeMo_AC TikTok: https://www.tiktok.com/@bemoacademicconsulting
At the end of 2024 I sat down with Dr. Meng Chiang, the Executive Director of the 2024 Taiwanese American Conference- East Coast. We had a really wonderful heart-centered conversation about the conference theme Collective Memory and that led to collective trauma as it relates to the Taiwanese and Taiwanese American communities. We talked about the 4 types of trauma responses, the 4 Fs- flight, fight, freeze and fawn and post-traumatic growth. Related Links: https://talkingtaiwan.com/collective-memory-collective-trauma-a-conversation-with-meng-chiang-ep-339/ This episode is dedicated to the memory of Sharon Huang, who passed away in December of 2025. She was a dear friend, mother, wife, sister, auntie, a community organizer and a cornerstone of the Taiwanese American community, especially in New York where she resided. Most notably she and her husband Patrick Huang ran the Brooklyn Artists Studio (BAS) and have supported the Taiwanese American Arts Council (TAAC) and Talking Taiwan. Together they have advocated for Taiwan democracy, human rights, and culture. The loss of Sharon is felt by so many who knew and loved her, she leaves behind family in the U.S. and Taiwan. Mengchun "Meng" Chiang, PhD (she/her/hers), is a member of the Taiwanese American community. She has served in various community leadership roles, most recently as Executive Director of the Taiwanese American Conference East Coast (TACEC) in 2024. Professionally, Meng is the founder of CHI Executive Consulting, LLC, where she provides leadership coaching and consulting services, specializing in workplace inclusion and organizational wellness. She is passionate about empowering leaders from diverse backgrounds, helping them enhance their communication, negotiation, and inclusive leadership skills. Meng regularly facilitates workshops to help leaders integrate their identities into effective leadership practices that drive business success and personal growth. Meng is a licensed clinical psychologist with affiliations to Harvard Medical School, Carnegie Mellon University, the Tepper School of Business, and National Taiwan University. Her experience spans education, training, and leadership roles. She pioneered the Leadership and Connection for Asian Women+ Leaders program and served as Assistant Director of Training at Carnegie Mellon University. In her free time, Meng enjoys traveling, practicing loving-kindness meditation, listening to music, taking walks, and grocery shopping. Related Links: https://talkingtaiwan.com/collective-memory-collective-trauma-a-conversation-with-meng-chiang-ep-339/
Superpowers for Good should not be considered investment advice. Seek counsel before making investment decisions. When you purchase an item, launch a campaign or create an investment account after clicking a link here, we may earn a fee. Engage to support our work.Watch the show on television by downloading the e360tv channel app to your Roku, LG or AmazonFireTV. You can also see it on YouTube.Devin: What is your superpower?Eugene: Staying focused on a North Star.Eugene Chan, CEO and founder of rHEALTH, has taken blood diagnostics to new heights—literally. His innovative technology, capable of analyzing dozens of biomarkers from a single drop of blood, was tested aboard the International Space Station (ISS). In today's episode, Eugene shared the remarkable journey of rHEALTH, from competing with top companies for a NASA partnership to launching its device into space.What sets rHEALTH apart is its proven reliability in extreme conditions, including the zero-gravity environment of space. Eugene explained, “We tested this technology on the International Space Station with astronaut Samantha Cristoforetti, who operated the device and obtained precise values from single drops of sample. They did the analysis using our device and got absolutely the right answers.” This achievement underlines the robustness and accuracy of rHEALTH's technology, qualities that distinguish it from other attempts at single-drop blood diagnostics.Unlike Theranos, which famously failed to deliver on similar promises, rHEALTH's technology has been rigorously vetted. Eugene highlighted the grueling process of earning NASA's trust. “To be the one company selected to demonstrate our novel technology on the ISS was a huge undertaking,” he said. He recounted the intense competition and NASA's exacting standards, which included testing the device's functionality during zero-gravity parabolic flights.Now, Eugene and his team are bringing this groundbreaking technology to the public with a regulated crowdfunding campaign on StartEngine. “You don't have to be a Silicon Valley elite or a Boston venture capitalist to participate,” I noted during the episode. With this campaign, everyday investors have the opportunity to support a proven technology poised to revolutionize healthcare.The implications of rHEALTH's success are profound. If it works in space, it can work in remote clinics, underserved communities, and even in people's homes. This technology has the potential to make diagnostics more accessible, empowering individuals to take control of their health.Eugene's vision, combined with rHEALTH's proven track record, makes this an exciting investment opportunity. Visit StartEngine to learn more and become part of this revolutionary journey.tl;dr:Eugene Chan shared how rHEALTH's diagnostic technology was tested and proven aboard the International Space Station.He explained the rigorous process of competing with other companies to secure NASA's trust.rHEALTH's crowdfunding campaign on StartEngine makes investing in this revolutionary technology accessible to all.Eugene highlighted the importance of his North Star: improving human health with innovative solutions.He shared advice on maintaining focus and using challenges as opportunities to achieve big goals.How to Develop Staying Focused on a North Star As a SuperpowerEugene's superpower is his ability to maintain a relentless focus on his “North Star”—the overarching goal of improving human health. As he explained, “The North Star has always been to improve the human condition and help us improve human health.” For Eugene, this guiding principle has driven his work through challenges, from competing for NASA's attention to developing groundbreaking diagnostic technology.One illustrative story of this superpower came during a pivotal moment in Eugene's career. While competing in the XPRIZE competition, he found himself grappling with a flawed prototype. It was during this time, sitting at his wife's bedside after the birth of their child, that the concept for rHEALTH's current device was born. Combining the pressure of the competition, the inspiration of his newborn daughter, and his unwavering focus on creating a robust solution, Eugene developed the technology that would later achieve success in space.Eugene also shared actionable tips for developing this superpower:Identify your personal North Star—a goal or mission that deeply resonates with you.Let that North Star guide your decisions, especially during challenging times.Stay committed to your mission, even when facing setbacks or obstacles.Use external pressures, like deadlines or competitions, to fuel innovation and progress.By following Eugene's example and advice, you can make staying focused on a North Star a skill. With practice and effort, you could make it a superpower that enables you to do more good in the world.Remember, however, that research into success suggests that building on your own superpowers is more important than creating new ones or overcoming weaknesses. You do you!Guest ProfileEugene Chan (he/him):CEO, Founder, rHEALTHAbout rHEALTH: rHEALTH has worked with NASA to develop a miniaturized diagnostic test system to keep astronauts healthy on the way to Mars. We have successfully tested this onboard the International Space Station and published the results in Nature Communications, demonstrating results from blood in minutes in extreme environments. The technology shrinks a central clinical lab and a team of doctors in a form suitable for everyday use. Comprehensive lab-quality analysis can be performed by anyone, fundamentally shifting diagnostics from centralized facilities to the point-of-care and homes. The focus is to usher in Diagnostics 2.0, allowing high-value multiplexed diagnostics.Website: rhealth.comOther URL: startengine.com/offering/rhealthBiographical Information: Dr. Chan is a physician-inventor. He is currently Founder, CEO of rHEALTH, and President, CSO of DNA Medicine Institute, a medical innovation laboratory. He has been honored as Esquire magazine's Best and Brightest, one of MIT Technology Review's Top 100 Innovators, and an XPRIZE winner. His work has contributed to the birth of next-generation sequencing, health monitoring in remote environments, and therapeutics. Dr. Chan holds over 60 patents and publications, with work funded by the NIH, NASA, and USAF. Dr. Chan received an A.B. in Biochemical Sciences from Harvard College summa cum laude in 1996, received an M.D. from Harvard Medical School with honors in 2007, and trained in medicine at the Brigham and Women's Hospital. He has been in zero gravity and led the team that demonstrated the rHEALTH ONE bioanalyzer onboard the International Space Station.LinkedIn Profile: linkedin.com/in/eugene-chan-4220045Personal Twitter Handle: @Dr_EugeneChanSupport Our SponsorsOur generous sponsors make our work possible, serving impact investors, social entrepreneurs, community builders and diverse founders. Today's advertisers include Crowdfunding Made Simple. Learn more about advertising with us here.Max-Impact Members(We're grateful for every one of these community champions who make this work possible.)Brian Christie, Brainsy | Cameron Neil, Lend For Good | Carol Fineagan, Independent Consultant | Hiten Sonpal, RISE Robotics | John Berlet, CORE Tax Deeds, LLC. | Justin Starbird, The Aebli Group | Lory Moore, Lory Moore Law | Mark Grimes, Networked Enterprise Development | Matthew Mead, Hempitecture | Michael Pratt, Qnetic | Mike Green, Envirosult | Dr. Nicole Paulk, Siren Biotechnology | Paul Lovejoy, Stakeholder Enterprise | Pearl Wright, Global Changemaker | Scott Thorpe, Philanthropist | Sharon Samjitsingh, Health Care Originals | Add Your Name HereUpcoming SuperCrowd Event CalendarIf a location is not noted, the events below are virtual.SuperGreen Live, January 22–24, 2026, livestreaming globally. Organized by Green2Gold and The Super Crowd, Inc., this three-day event will spotlight the intersection of impact crowdfunding, sustainable innovation, and climate solutions. Featuring expert-led panels, interactive workshops, and live pitch sessions, SuperGreen Live brings together entrepreneurs, investors, policymakers, and activists to explore how capital and climate action can work hand in hand. With global livestreaming, VIP networking opportunities, and exclusive content, this event will empower participants to turn bold ideas into real impact. Don't miss your chance to join tens of thousands of changemakers at the largest virtual sustainability event of the year. Learn more about sponsoring the event here. Interested in speaking? Apply here. Support our work with a tax-deductible donation here.SuperCrowd Impact Member Networking Session: Impact (and, of course, Max-Impact) Members of the SuperCrowd are invited to a private networking session on January 27th at 1:30 PM ET/10:30 AM PT. Mark your calendar. We'll send private emails to Impact Members with registration details.Community Event CalendarSuccessful Funding with Karl Dakin, Tuesdays at 10:00 AM ET - Click on Events.Join C-AR Annual Reporting: Requirements, Deadlines, and Lessons Learned from the Field on January 14, 2026, an informative online webinar designed to help crowdfunding issuers and professionals clearly understand C-AR annual reporting requirements, key deadlines, and real-world insights to stay compliant and prepared.Join UGLY TALK: Women Tech Founders in San Francisco on January 29, 2026, an energizing in-person gathering of 100 women founders focused on funding strategies and discovering SuperCrowd as a powerful alternative for raising capital.If you would like to submit an event for us to share with the 10,000+ changemakers, investors and entrepreneurs who are members of the SuperCrowd, click here.Manage the volume of emails you receive from us by clicking here.We use AI to help us write compelling recaps of each episode. Get full access to Superpowers for Good at www.superpowers4good.com/subscribe
Restless legs syndrome is a sleep-related neurologic disorder that causes an overwhelming urge to move the limbs, which can cause substantial sleep disturbance. Author John W. Winkelman, MD, PhD, of Harvard Medical School joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the symptoms, risk factors, diagnosis, and treatment of restless legs syndrome. Related Content: Restless Legs Syndrome
Born in Tustin, California, James Nestor spent his teens surfing and playing in a straight-edge punk band called Care Unit. After graduating high school, he moved to the Bay Area, where he studied art and literature and earned an MFA. Nestor's professional life began as a copywriter. Soon he moved into magazine journalism. His essays and features have appeared in Outside, Scientific American, The New York Times, The Atlantic, Dwell, The Surfer's Journal, and many others. His 2014 book, DEEP: Freediving, Renegade Science, and What the Ocean Tells Us About Ourselves, follows clans of extreme athletes, adventurers, and scientists as they plumb the ocean's depths and uncover surprising new discoveries. But his big book is, of course, 2020's Breath: The New Science of a Lost Art, which explores the million-year-long history of how we humans have lost the ability to breathe properly, and why we're suffering from various maladies because of it. Along with drawing on thousands of years of medical texts and recent cutting-edge studies in pulmonology, psychology, biochemistry, and human physiology, Nestor also found answers in the muddy digs of ancient burial sites, secret Soviet facilities, New Jersey choir schools, and the smoggy streets of Sao Paulo. In sum, Breath turns the conventional wisdom of what we thought we knew about our most basic biological function on its head. Nestor has been a guest speaker at Stanford Medical School, Harvard Medical School, Yale School of Medicine, and the United Nations. He currently lives in Portugal. In this episode of Soundings, Nestor talks with Jamie Brisick about the fundamentals of breathwork, Ocean Beach, growing up in Orange County, his early days as a reporter, the values of freediving, and writing books. Produced by Jonathan Shifflett. Music by PazKa (Aska Matsumiya & Paz Lenchantin).
In this episode, Christina sits down with Jacob Hooker for a candid conversation at the intersection of coaching, mentorship, and mental health. Together, they unpack the psychology of growth, the science of change, and why curiosity is one of the most overlooked tools in personal development.Jacob shares how his journey from academia to entrepreneurship led him to focus on the mental health crisis, and how innovative therapeutic approaches, including psychedelic-assisted treatments, are reshaping what's possible.About The Guest: Jacob Hooker, PhD, is a neuroscientist, entrepreneur, and CEO of Sensorium Therapeutics, a biotechnology company developing nature-inspired medicines for mental health. Jacob previously served as an endowed professor at Harvard Medical School and a scientific leader at Massachusetts General Hospital, where his research helped advance new approaches for understanding the brain and treating psychiatric disease. His work sits at the intersection of neuroscience, chemistry, and human well-being—with a focus on creating better, faster-acting treatments for anxiety and stress.Connect with Jacob on LinkedInLearn more about Sensorium TherapeuticsFollow Jacob on Substack If you enjoyed this episode, make sure and give us a five star rating and leave us a comment on iTunes, Podcast Addict, Podchaser and Castbox about what you'd like us to talk about that will help you realize that at any moment, any day, you too can decide, it's your turn!
In this episode of the SHE MD Podcast, Dr. Azadeh Shirazi joins Dr. Thaïs Aliabadi and Mary Alice Haney for a real, science-backed conversation about skincare, anti-aging, fillers, retinol, vitamin C, and hair, lash, and brow health. They break down what actually works, how to build a smart daily routine, and why small tweaks can make a big difference in your results.Dr. Shirazi clears up common filler myths, explains how to keep results looking natural, and shares easy tips for using retinol and vitamin C without irritation. The conversation also covers safe, practical options for supporting hair and lash growth.If you're dealing with acne, curious about cosmetic treatments, or just want healthier skin and hair, this episode offers clear, expert advice you can actually use—without the overwhelm.Subscribe to SHE MD Podcast for expert tips on PCOS, Endometriosis, fertility, and hormonal balance. Share with friends and visit SHE MD website and Ovii for research-backed resources, holistic health strategies, and expert guidance on women's health and well-being.Sponsors:Ka'Chava - Rewild your nutrition at kachava.com and use code SHEMD. New customers get $20 off an order of two bags or more, now through Jan 31st!Midi Health - Ready to feel your best and write your second act script? Visit JoinMidi.com today to book your personalized, insurance-covered virtual visit. ButcherBox - As an exclusive offer, new listeners can get their choice between filet mignon,NY strip or chicken breast in every box for a year, PLUS $20 off when you go to ButcherBox.com/SHEMD Mill - Try Mill risk-free for 90 days and get $75off at mill.com/SHEMD and use code SHEMD at checkout.Peloton - Let yourself run, lift, sculpt, push, and go. Explore the new Peloton Cross Training Tread+ at onepeloton.com What You'll LearnHow fillers affect lymphatic drainage and the risks of overuseRetinol staging techniques to reduce irritation and maximize benefitsEffective skincare routines: cleanse, treat, protectHair, lash, and eyebrow growth tips and risks of prostaglandin-based serumsKey Timestamps00:00 Introduction with Dr. Thaïs Aliabadi and Mary Alice Haney05:00 Dr. Azadeh Shirazi's background and how she started her dermatology practice07:00 Discussion around CO2 lasers09:00 Difference between BBL and CO2 lasers27:00 Does red light therapy work?29:00 Safe use of hydrophilic vs. non-hydrophilic fillers under the eyes34:00 Lymphatic drainage and vascular occlusion risks explained42:30 Eyelash and eyebrow growth: effective and safe options50:30 Retinol staging and vitamin C tips to prevent irritation1:04:30 Teen acne management: simple routines and treatment strategies1:09:20 Hair loss and cosmetic solutions for women1:13:10 Foreign cosmetic treatments1:18:00 Rapid fire questions and takeaways for maintaining healthy skin and hairKey Takeaways Cosmetic treatments must be patient-specific to prevent complicationsConsistent, simple routines are key to maintaining healthy skinRetinol and vitamin C provide major anti-aging benefits when used correctlyFillers replace volume rather than lifting, requiring careful planningHair and lash treatments need proper evaluation and safe applicationGuest BioDr. Azadeh Shirazi, MD is a board-certified dermatologist specializing in cosmetic dermatology and the inventor of EyeGlow® for dark circles. She completed her Dermatology Medical training at the Mayo Clinic and UC San Diego after receiving her medical degree from the University Of Kentucky College of Medicine. She developed and patented a brightening under-eye treatment called EyeGlow® using a white opaque filler blend to treat under-eye hollowness & dark circles. Dr. Shirazi completed a research fellowship at Harvard Medical School at the Wellman Center for Photomedicine. Her research involved investigating the effects of light and laser therapies on human biology. Dr. Shirazi specifically focused on innovative ways of using various wavelengths of light in the reduction of inflammation. She worked closely with Dr. Hamblin at the Harvard Medical School looking at new diagnostic and therapeutic uses of laser energy in wound healing, cancer cells, and atherosclerotic plaques.LinksInstagram – @skinbydraziFacebook – La Jolla Med SpaTikTok - @skinbydrazi La Holla Laser DermSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Moyamoya Syndrome Stroke Recovery: Judy Kim Cage's Comeback From “Puff of Smoke” to Purpose At 4:00 AM, Judy Kim Cage woke up in pain so extreme that she was screaming, though she doesn't remember the scream. What she does remember is the “worst headache ever,” nausea, numbness, and then the terrifying truth: her left side was shutting down. Here's the part that makes her story hit even harder: Judy already lived with Moyamoya syndrome and had undergone brain surgeries years earlier. She genuinely believed she was “cured.” So when her stroke began, her brain fought the reality with everything it had. Denial, resistance, bargaining, and delay. And yet, Judy's story isn't about doom. It's about what Moyamoya syndrome stroke recovery can look like when you keep going, especially when recovery becomes less about “getting back to normal” and more about building a new, honest, meaningful life. What Is Moyamoya Syndrome (And Why It's Called “Puff of Smoke”) Moyamoya is a rare cerebrovascular disorder where the internal carotid arteries progressively narrow, reducing blood flow to the brain. The brain tries to compensate by creating fragile collateral vessels, thin-walled backups that can look like a “puff of smoke” on imaging. Those collateral vessels can become a risk. In Judy's case, the combination of her history, symptoms, and eventual deficits marked a devastating event that would reshape her life. The emotional gut punch wasn't only the stroke itself. It was the psychological whiplash of thinking you're safe… and discovering you're not. The First Enemy in Moyamoya Stroke Recovery: Denial Judy didn't just resist the hospital. She resisted the idea that this was happening at all. She'd been through countless ER visits in the past, having to explain Moyamoya to doctors, enduring tests, and then being told, “There's nothing we can do.” That history trained her to expect frustration and disappointment, not urgent help. So when her husband wanted to call emergency services, her reaction wasn't logical, it was emotional. It was the reflex of someone who'd been through too much. Denial isn't weakness. It's protection. It's your mind trying to buy time when the truth is too big to hold all at once. The Moment Reality Landed: “I Thought I Picked Up My Foot” In early recovery, Judy was convinced she could do what she used to do. Get up. Walk. Go to the bathroom. Handle it. But a powerful moment in rehab shifted everything: she was placed into an exoskeleton and realized her brain and body weren't speaking the same language. She believed she lifted her foot, then saw it hadn't moved for several seconds. That's when she finally had to admit what so many survivors eventually face: Recovery begins the moment you stop arguing with reality. Not because you “give up,” but because you stop wasting energy fighting what is and start investing energy into what can be. The Invisible Battle: Cognitive Fatigue and Energy Management If you're living through Moyamoya syndrome stroke recovery, it's easy for everyone (including you) to focus on the visible stuff: walking, arms, vision, and balance. But Judy's most persistent challenge wasn't always visible. It was cognitive fatigue, the kind that makes simple tasks feel impossible. Even something as ordinary as cleaning up an email inbox can become draining because it requires micro-decisions: categorize, prioritize, analyze, remember context, avoid mistakes. And then there's the emotional layer: when you're a perfectionist, errors feel personal. Judy described how fatigue increases mistakes, not because she doesn't care, but because the brain's bandwidth runs out. That's a brutal adjustment when your identity has always been built on competence. A practical shift that helped her Instead of trying to “finish” exhausting tasks in one heroic sprint, Judy learned to do small daily pieces. It's not glamorous, but it reduces cognitive load and protects energy. In other words: consistency beats intensity. Returning to Work After a Moyamoya Stroke: A Different Kind of Strength Judy's drive didn't disappear after her stroke. If anything, it became part of the recovery engine. She returned slowly, first restricted to a tiny number of hours. Even that was hard. But over time, she climbed back. She eventually returned full-time and later earned a promotion. That matters for one reason: it proves recovery doesn't have one shape. For some people, recovery is walking again. For others, it's parenting again. For others, it's working again without losing themselves to burnout. The goal isn't to recreate the old life perfectly. The goal is to build a life that fits who you are now. [Quote block mid-article] “If you couldn't make fun of it… it would be easier to fall into a pit of despair.” Humor Isn't Denial. It's a Tool. Judy doesn't pretend everything is okay. She's not selling toxic positivity. But she does use humor like a lever, something that lifts the emotional weight just enough to keep moving. She called her recovering left hand her “evil twin,” high-fived it when it improved, and looked for small “silver linings” not because the stroke was good, but because despair is dangerous. Laughter can't fix Moyamoya. But it can change what happens inside your nervous system: tension, stress response, mood, motivation, and your willingness to try again tomorrow. And sometimes, tomorrow is the whole win. Identity After Stroke: When “Big Stuff Became Small Stuff” One of the most profound shifts Judy described was this: the stroke changed her scale. Things that used to feel huge became small. Every day annoyances lost their power. It took something truly significant to rattle her. That's not magical thinking. That's a perspective earned the hard way. Many survivors quietly report this experience: once you've faced mortality and rebuilt your life from rubble, you stop wasting precious energy on what doesn't matter. Judy also found meaning in mentoring others because recovering alone can feel like walking through darkness without a map. Helping others doesn't erase what happened. But it can transform pain into purpose. If You're In Moyamoya Syndrome Stroke Recovery, Read This If your recovery feels messy… if you're exhausted by invisible symptoms… if the old “high achiever” version of you is fighting the new reality… You're not broken. You're adapting. And your next step doesn't have to be dramatic. It just has to be honest and repeatable: Simplify the day Protect energy Build routines Accept help Use humor when you can And find one person who understands Recovery is not a straight line. But it is possible to rebuild a life you actually want to live. If you want more support and guidance, you can also explore Bill's resources here: recoveryafterstroke.com/book patreon.com/recoveryafterstroke This blog is for informational purposes only and does not constitute medical advice. Please consult your doctor before making any changes to your health or recovery plan. Judy Kim Cage on Moyamoya Stroke Recovery, Cognitive Fatigue, and Finding Purpose Again She thought Moyamoya was “fixed.” Then a 4 AM headache proved otherwise. Judy's comeback will change how you see recovery. Judy’s Instagram Highlights: 00:00 Introduction and Guest Introduction 01:43 Life Before the Stroke 11:17 The Moment of the Stroke 19:56 Moyamoya Syndrome Stroke Recovery 25:36 Cognitive Fatigue and Executive Functioning 34:50 Rehabilitation Experience 42:29 Using Humor in Recovery 46:59 Finding Purpose After Stroke 54:19 Judy’s Book: Super Survivor 01:05:20 Conclusion and Final Thoughts Transcript: Introduction and Guest Introduction Bill Gasiamis (00:00) Hey there, I’m Bill Gasiamis and this is the Recovery After Stroke podcast. Before we jump in a quick thank you to my Patreon supporters. You help cover the hosting costs after more than 10 years of doing this independently. And you make it possible for me to keep creating episodes for stroke survivors who need hope and real guidance. And thank you to everyone who supports the show in the everyday ways too. The YouTube commenters, the people leaving reviews on Spotify and Apple. The folks who bought my book and everyone who sticks around and doesn’t skip the ads. I see you and I appreciate you. Now I want you to hear this. My guest today, Judy Kim Cage, woke up at 4am with the worst headache of her life and she was so deep in denial that she threatened to divorce her husband if he called 911. Judy lives with Moyamoya syndrome, a rare cerebrovascular condition often described as the puff of smoke on imaging. She’d already had brain surgeries and believed she was cured until the stroke changed everything. Judy also wrote a book called Super Survivor and it’s all about how denial, resistance and persistence can lead to success and a better life after stroke. I’ll put the links in the show notes. In this conversation, we talk about Moyamoya Syndrome, stroke recovery, the rehab moment where reality finally landed. and what it’s like to rebuild life with cognitive fatigue and executive functioning challenges and how Judy used humor and purpose to keep moving forward without pretending recovery is easy. Let’s get into it. Judy Kim Cage, welcome to the podcast. Life Before Moyamoya Syndrome Judy Kim Cage (01:43) Thank you so much, Bill Bill Gasiamis (01:45) Thanks for being here. Can you paint us a picture of your life before the stroke? What were your days like? Judy Kim Cage (01:51) Hmm. Well, my life before the stroke was me trying to be a high achiever and a corporate nerd. I think so. I think so. I, you know, I was in the Future Business Leaders of America in high school and then carried that forward to an accounting degree. Bill Gasiamis (02:04) Did you achieve it? Judy Kim Cage (02:20) and finance and then ⁓ had gone to work for Deloitte and the big four. ⁓ And after that moved into ⁓ internal audit for commercial mortgage and then risk and banking and it all rolled into compliance, which is a kind of larger chunk there. But ⁓ yeah, I was living the corporate dream and Traveling every other week, basically so 50 % of the time, flying to Columbus, staying there, and then flying back home for the weekend and working in a rented office for the week after. And I did that for all of 2018. And then in 2019 is when my body said, hang on a second. And I had a stroke. Bill Gasiamis (03:17) How many hours a week do you think you were working? Judy Kim Cage (03:19) Well, not including the treble, ⁓ probably 50-55. Bill Gasiamis (03:26) Okay. Judy Kim Cage (03:26) Oh, wish, that wasn’t that that really wasn’t a ton compared to my Deloitte days where I’d be working up to 90 hours a week. Bill Gasiamis (03:37) Wow. in that time when you’re working 90 hours a week. Is there time for anything else? you get to squeeze in a run at the gym or do you get to squeeze in a cafe catch up with a friend or anything like that? Judy Kim Cage (03:51) There are people that do. think, yeah, I mean, on certain particular weekends and my friends, a lot of my friends were also working with me. So there was time to socialize. And then, of course, we would all let off some steam, you know, at the pub, you know, at the end of a week. But ⁓ yeah, I remember on one of my very first jobs, I had been so excited because I had signed up to take guitar lessons and I was not able to leave in order to get there in time. ⁓ so that took a backseat. Bill Gasiamis (04:40) Yes, it sounds like there’s potentially lots of things that took a backseat. Yeah, work tends to be like that can be all consuming and when friendships especially are within the work group as well, even more so because everyone’s doing the same thing and it’s just go, Judy Kim Cage (04:44) Yeah, definitely. Absolutely. We started as a cohort essentially of, I want to say 40 some people all around the same age. And then, you know, as the years ticked by, we started falling off as they do in that industry. Bill Gasiamis (05:19) Do you enjoy it though? Like, is there a part of you that enjoys the whole craziness of all the travel, all the hours, the work stuff? it? Is it like interesting? Judy Kim Cage (05:31) Yeah, I do love it. I actually do love my job. I love compliance. I love working within a legal mindset with other lawyers. And basically knowing that I’m pretty good at my job, that I can be very well organized, that it would be difficult even for a normal healthy person and challenging and that I can do well there. And yeah, no, was, when I had put in a year, when I was in ⁓ acute therapy, ⁓ I had spoken with a number of students and they had interviewed me as a patient, but also from the psych side of it all, ⁓ asking, well, what does it feel like to all of a sudden have your life stop? And I said, well, ⁓ and things got a bit emotional, I said, I felt like I was at the top of my game. I had finally achieved the job that I absolutely wanted, had desired. ⁓ I felt like I’d found a home where I was now going to retire. And all of a sudden that seems like it was no longer a possibility. Bill Gasiamis (06:55) So that’s a very common thing that strokes have over say who I interviewed. They say stuff like I was at the top of my game and there’s this ⁓ idea or sense that once you get to the top of the game, you stay there. There’s no getting down from the top of the game and that it just keeps going and keeps going. And, I think it’s more about fit. sounds like it’s more about fit. Like I found a place where I fit. found a place where I’m okay. or I do well, where I succeed, where people believe in me, where I have the support and the faith or whatever it is of my employers, my team. Is that kind of how you describe on top of your game or is it something different? Judy Kim Cage (07:41) I think it was all of those things, ⁓ but also, you know, definitely the kindness of people, the support of people, their faith in my ability to be smart and get things done. But then also ⁓ just the fact that I finally said, okay, this was not necessarily a direct from undergrad to here. However, I was able to take pieces of everything that I had done and put it together into a position that was essentially kind of created for me and then launched from there. So I felt as though it was essentially having climbed all of those stairs. So I was at the top. Yeah. you know, looking at my Lion King kingdom and yeah. Bill Gasiamis (08:43) just about to ascend and, and it was short lived by the sound of it. Judy Kim Cage (08:49) It was, it was, it was only one year beforehand, but I am actually still at the company now. I ⁓ had gone and done ⁓ well. So I was in the hospital for a few months and following that. Well, following the round of inpatient and the one round of outpatient, said, okay, I’m going back. And I decided, I absolutely insisted that I was going to go back. The doctor said, okay, you can only work four hours a week. I said, four hours a week, what are you talking about? ⁓ But then I realized that four hours a week was actually really challenging at that time. ⁓ And then ⁓ I climbed back up. was, you know, I’m driven by deadlines and… ⁓ I was working, you know, leveraging long-term disability. And then once I had worked too many hours after five years, you know, I graduated from that program, or rather I got booted out of the program. ⁓ And then a year later, I was actually, well, no, actually at the end of the five years I was promoted. So, ⁓ after coming back full time. Bill Gasiamis (10:20) Wow. So this was all in 2019, the stroke. You were 39 years old. Do you remember, do you remember the moment when you realized there was something wrong? We’ll be back with more of Judy’s remarkable story in just a moment. If you’re listening right now and you’re in that stage where recovery feels invisible, where the fatigue is heavy, your brain feels slower. or you’re trying to explain a rare condition like Moyamoya and nobody really gets it. I want you to hear this clearly. You’re not failing. You’re recovering. If you want extra support between episodes, you can check out my book at recoveryafterstroke.com slash book. And if you’d like to help keep this podcast going and support my mission to reach a thousand episodes, you can support the podcast at Patreon by visiting patreon.com/recoveryafterstroke. All right, let’s get back to Judy. The Moment of the Stroke Judy Kim Cage (11:16) Yes, although I was in a lot of denial. ⁓ So we had just had dinner with ⁓ my stepdaughter and her husband ⁓ and ⁓ we were visiting them in Atlanta, Georgia. ⁓ And we said, OK, we’ll meet for brunch tomorrow. You know, great to see you. Have a good night. It was four in the morning and I was told I woke up screaming and I felt this horrible, horrible worst headache ever ⁓ on the right side. And I think because I have, I have Moyamoya syndrome, because of that and because I had had brain surgeries, ⁓ 10 years or back in December of 2008, I had a brain surgery on each side. And that at the time was the best of care that you could get. You know, that was essentially your cure. And so I thought I was cured. And so I thought I would never have a stroke. So when it was actually happening, I was in denial said there’s no way this could be happening. But the excess of pain, ⁓ the nausea and ⁓ it not going away after throwing up, the numbness ⁓ and then the eventual paralysis of my left side definitely ⁓ was evidence that something was very very wrong. Bill Gasiamis (13:09) So it was four in the morning, were you guys sleeping? Judy Kim Cage (13:14) ⁓ yeah, we were in bed. Yep. And yeah, I woke up screaming. According to my husband, I don’t remember the screaming part, but I remember all the pain. Bill Gasiamis (13:24) Yeah, did he ⁓ get you to hospital? Did he the emergency services? Judy Kim Cage (13:30) I apparently was kind of threatening to divorce him if he called 911. Bill Gasiamis (13:38) Wow, that’s a bit rough. Oh my lord. Judy Kim Cage (13:41) I know. mean, that could have been his out, but he didn’t. Bill Gasiamis (13:45) There’s worse things for a human to do than call 911 and get your support. Like marriages end for worse things than that. Judy Kim Cage (13:53) because I’ve been to the ER many, many, many times. And because of the Moyamoya, you would always, it being a rare disease, you would never be told, well, you would have to explain to all the doctors about what Moyamoya was, for one. For two, to say if I had a cold, for instance, that Moyamoya had nothing to do with it. Bill Gasiamis (14:11) Wow. Judy Kim Cage (14:19) But also, you know, they would give me an MRI, oof, the claustrophobia. I detested that. And I said, if you’re getting me into an MRI, please, please, please, a benzodiazepine would be incredible. Or just knock me out, whatever you need to do. But I’m not getting into that thing otherwise. But, you know, they would take the MRI, read it. and then say, hours and hours and hours later, there’s nothing we can do. The next course of action, if it was absolutely necessary, would be another surgery, which would have been bur holes that were drilled into my skull to relieve some sort of pressure. ⁓ In this particular case, the options were to ⁓ have a drain put in my skull. and then for me to be reliant on a ventilator. Or they said, you can have scans done every four hours and if the damage becomes too great, then we’ll move on. Otherwise, we’ll just keep tabs on it, essentially. Bill Gasiamis (15:37) Yeah. So I know that feeling because since my initial blade in February, 2012, I’ve lost count how many times I’ve been to the hospital for a scan that was unnecessary, but necessary at the time because you, you know, you tie yourself up in knots trying to work out, is this another one? Isn’t it another one? Is it, it, and then the only outcome that you can possibly come up with that puts your mind at ease and everybody else around you is let’s go and get a scan and then, and then move on with life. Once they tell you it was, ⁓ it was not another bleed or whatever. Yeah. However, three times I did go and three times there was a bleed. So it’s the whole, you know, how do you wrap your head around like which one isn’t the bleed, which one is the bleed and It’s a fricking nightmare if you ask me. And I seem to have now ⁓ transferred that concern to everybody else who has a headache. On the weekend, my son had a migraine. And I tell you what, because he was describing it as one of the worst headaches he had ever had, I just went into meltdown. I couldn’t cope. And it was like, go to the hospital, go to the hospital, go to… He didn’t go, he’s an adult, right? Makes his own decisions. But I was worried about it for days. And it wasn’t enough that even the next few days he was feeling better because I still have interviewed people who have had a headache for four or five or six days before they went to hospital and then they found that it was a stroke. it’s just become this crazy thing that I have to live with now. Judy Kim Cage (17:26) I essentially forced Rich to wait 12 hours before I called my vascular neurologist. And once I did, his office said, you need to go to the ER. And I said, okay, then that’s when I folded and said, all right, we’ll go. ⁓ And then, ⁓ you know, an ambulance came. Bill Gasiamis (17:35) Wow. Judy Kim Cage (17:53) took me out on a gurney and then took me to a mobile stroke unit, which there was only one of 11, there were only 11 in the country at the time. And they were able to scan me there and then had me basically interviewed by a neurologist via telecall. And this was, you know, before the days of teams and zoom and that we all tested out ⁓ from COVID. ⁓ yeah, that’s. Bill Gasiamis (18:35) That’s you, So then you get through that initial acute phase and then you wake up with a certain amount of deficits. Judy Kim Cage (18:37) Yeah. my gosh. ⁓ Well, yeah, absolutely. ⁓ Massive amounts of pain ⁓ from all the blood absorbing back into the brain. ⁓ The left side, my left side was paralyzed. My arm fell out of my shoulder socket. So it was hanging down loosely. ⁓ I had dropped foot, so I had to learn to walk again. Double vision and my facial group on the left and then. Bluff side neglect. Bill Gasiamis (19:31) Yeah. So, and then I see in our, in your notes, I see also you had diminished hearing, nerve pain, spasticity, cognitive fatigue, ⁓ bladder issues. You’d also triggered Ehlers-Danlos symptoms, whatever that is. Tell me about that. What’s that? Moyamoya Syndrome Stroke Recovery Judy Kim Cage (19:56) So I call myself a genetic mutant because the Moyamoya for one at the time I was diagnosed is discovered in 3.5 people out of a million. And then Ehlers-Danlos or EDS for short is also a genetic disorder. Well, certain versions are more genetic than others, but it is caused by a defect in your collagen, which makes up essentially your entire body. And so I have hypermobility, the blood, I have pots. So my, my blood basically remains down by my feet, it pulls at my feet. And so not enough of it gets up to my brain, which also could, you know, have affected the moimoya. But Essentially, it creates vestibular issues, these balance issues where it’s already bad enough that you have a stroke, but it’s another to be at the risk of falling all the time. Yeah. Or if you get up a little too fast, which I still do to this day, sometimes I’ll completely forget and I’ll just bounce up off the sofa to get myself a drink and I will sway and all of a sudden Bill Gasiamis (21:07) Yeah. Judy Kim Cage (21:22) onto the sofa or sit down right on the floor and say, okay, why did I not do the three-step plan to get up? ⁓ But sometimes it’s just too easy to forget. Bill Gasiamis (21:37) Yeah, yeah. You just act, you just move out of well habit or normal, normal ways that people move. And then you find yourself in a interesting situation. So I mean, how, how do you deal with all of that? Like you, you go from having experienced more and more by the way, let’s describe more and more a little bit, just so people know what it is. Judy Kim Cage (22:02) Absolutely. So, my way is a cerebrovascular disorder where your internal carotid progressively constricts. So for no known reason, no truly known reason. And so because it keeps shrinking and shrinking, not enough brain, blood gets to your brain. So what the brain decides to do to compensate is it will form these collateral vessels. And these collateral vessels, which there are many of them usually, you know, the longer this goes on, ⁓ they have very thin walls. So due to the combination of the thin walls, and if you have high blood pressure, these walls can break. And that is what happened in my case. ⁓ Well, the carotids will continue to occlude, but what happens is, ⁓ least with the surgery, they took my temporal artery, removed it from my scalp, had taken a plate off of my skull and stitched that. temporal artery onto my brain so that it would have a separate source of blood flow so that it was no longer reliant on this carotid. So we know that the carotid, sorry, that the temporal artery won’t fail out. ⁓ So usually, ⁓ and this was my surgery was actually done at Boston Children’s Hospital ⁓ by the man who pioneered the surgery. And he was basically head of neurosurgery at Harvard Medical School and Boston Children’s because they more often find this in children now. And the sooner they find it, the fewer collateral vessels will form once the surgery is performed. Bill Gasiamis (24:17) Okay, so the long-term risk is that it’s decreased, the risk of a blade decreases if they do the surgery early on too. I love that. Judy Kim Cage (24:25) The rest. But I was diagnosed at the age of 29. So I had quite a while of these collateral vessels forming in what they call a puff of smoke that appears on the MRI. ⁓ And that is what, you know, Moyamoya essentially means in Japanese, is translated to in Japanese, it’s puff of smoke. Bill Gasiamis (24:50) Wow, you have been going through this for a while then. So I can understand your whole mindset around doctors, another appointment, another MRI. Like I could totally, ⁓ it makes complete sense. You you’re over it after a certain amount of time. Yeah, I’m the same. I kind of get over it, but then I also have to take action because you know what we know what the previous Judy Kim Cage (25:07) Absolutely. Bill Gasiamis (25:19) outcome was and now you’re dealing with all of these deficits that you have to overcome. Which are the deficits that you’re still dealing with that are the most, well, the most sort of prolonged or challenging or whatever you want to call them, whatever. Cognitive Fatigue and Executive Functioning Judy Kim Cage (25:34) The most significant, I guess it’s the most wide ranging. But it is. ⁓ Energy management and cognitive fatigue. ⁓ I have issues with executive functioning. ⁓ Things are, you know, if I need to do sorting or filing. ⁓ That actually is. one of my least favorite things to do anymore. Whereas it was very easy at one point. ⁓ And now if I want to clean up my inbox, it is just a dreaded task. ⁓ And so now I’ve learned that if I do a little bit of it every day, then I don’t have, it doesn’t have to take nearly as long. ⁓ Bill Gasiamis (26:26) What it’s dreaded about it is it making decisions about where those emails belong, what to do to them or. Judy Kim Cage (26:33) Oh, no, it’s just the time and energy it takes to do it. It drains me very quickly. Because you have to evaluate and analyze every line as you’re deciding what project it belongs to. And there’s a strategic way to do it in terms of who you normally deal with on each project, etc. etc. This chunk of time, calendar dates you’ve worked on it, etc. But, know, That might by the time I get to this tedious task, I’m not thinking about it strategically. ⁓ Yeah, I’m just dragging each individual line item into a little folder. ⁓ So, ⁓ but yeah, like the cognitive deficits. gosh. mean, I’m working on a computer all day. I am definitely a corporate desk rat or mouse, you know, on the wheel. ⁓ And a lot of Excel spreadsheets and just a lot of very small print and sometimes I get to expand it. ⁓ And it really is just trying not to, well, the job involves making as few errors as you possibly can. Bill Gasiamis (28:01) Yeah. Judy Kim Cage (28:02) ⁓ Now when I get tired or overwhelmed or when I overdo it, which I frequently frequently do, ⁓ I find out that I’ve made more errors and I find out after the fact usually. So nothing that’s not reversible, nothing that’s not fixable, but it still is pretty disheartening for a perfectionist type such as myself. Bill Gasiamis (28:30) Wow. So the perfectionism also has to become something that you have to deal with even more so than before, because before you were probably capable of managing it now, you’re less capable. yeah, I understand. I’m not a perfectionist by all means. My wife can tend to be when she’s studying or something like that. And she suffers from, you know, spending Judy Kim Cage (28:46) the energy. Bill Gasiamis (29:00) potentially hours on three lines of a paragraph. Like she’s done that before and I’ll just, and I’ve gone into the room after three hours and her, and her going into the room was, I’m going to go in and do a few more lines because she was drained or tired or, you know, her brain wasn’t working properly or whatever. I’m just going to go do three more lines and three hours later, she’s still doing those three lines. It’s like, wow, you need to get out of the, you need to get out. need to, we need to. break this because it’s not, it’s not good. So I totally get what it’s liked to be like that. And then I have had the cognitive fatigue where emails were impossible. Spreadsheets forget about it. I never liked them anyway. And they were just absolutely forget about it. Um, I feel like they are just evil. I feel like the spreadsheets are evil, you know, all these things that you have to do in the background, forget about it. That’s unbelievable. So, um, What was it like when you first sort of woke up from the initial stroke, got out of your unconscious state and then realized you had to deal with all of this stuff? I know for some time you were probably unable to speak and were you ⁓ trapped inside your body? Is that right or? Judy Kim Cage (30:19) I was in the ICU. I was paralyzed on the left side, so I was not able to get up, not really able to move much. ⁓ I was not speaking too much, definitely not within the first week. I was in the ICU for 10 days. ⁓ And yeah, I just wasn’t able to do much other than scream from the beam. ⁓ And then I, once I became more aware, I insisted that I could get up and walk to the bathroom myself. I insisted that I could just sit up, get up, do all the things that I had done before. And it being a right side stroke as well, you know, I think helps contribute to the overestimation or the… just conceitedness, guess, and this self-confidence that I could just do anything. Yes, absolutely. And I was told time and time again, Judy, can’t walk, Judy, can’t go to the bathroom, Judy, you can’t do these things. And I was in absolute denial. And I would say, no, I can, I can get up. And meanwhile, I would say that Bill Gasiamis (31:30) Delusion Judy Kim Cage (31:51) husband was so afraid that I was going to physically try to get up and fall over, which would not have been good. ⁓ And so, you know, there was, there were some expletives involved. ⁓ And, ⁓ and then eventually once I was out of the ICU, ⁓ I didn’t truly accept that I couldn’t walk until Bill Gasiamis (32:00) but. Judy Kim Cage (32:20) one of the PT students had put me into an exoskeleton and I realized that my foot did not move at all, you know, like a full five seconds after I thought I picked it up. And I said, wait, hang on, what’s going on here? And I said, ⁓ okay, I guess I have to admit that I can’t walk. And then I can’t, I can’t sit upright. I can’t. You know, and like you had mentioned, you know, I had lost the signals from my brain to my bladder. They were slow or whatnot. And I was wetting the bed, like a child at a sleepover. And I was pretty horrified. And that happened for, you know, pretty much my, pretty much all my time at Kratie, except I got the timing down. ⁓ eventually, which was fantastic. But then when I moved to post-acute, ⁓ then I had to learn the timing all over again, just because, you know, of different, rules being different, the transfers being different, and then, ⁓ you know, just ⁓ the timing of when somebody would answer the call button, et cetera. Bill Gasiamis (33:45) Yeah. Do you, what was it like going to rehab? I was really excited about it. I was hanging out because I learned that I couldn’t walk when the nurse said to me, have you been to the toilet yet? And I said, no, I hadn’t been to the toilet. We’re talking hours after surgery, you know, maybe within the first eight or nine hours, something like that. And I went to put my left foot down onto the ground. She was going to help me. She was like a really petite Asian. framed lady and I’m and I’m probably two feet taller than her, something like that, and double her weight. And then she said, just put your hand on my shoulder and then I’ll support you. So I did that. I put my hand on her shoulder, stepped onto my left foot and then just collapsed straight onto the ground and realized, ⁓ no, I’m not walking. I can’t walk anymore. And then I was then waiting. hanging out to go to rehab was really excited about that. ⁓ What was it like for you? Moyamoya Syndrome Stroke Rehabilitation Experience Judy Kim Cage (34:48) Initially, well, do you so you mean. ⁓ Bill Gasiamis (34:56) Just as in like, were you aware that you could ⁓ improve things? Were you kind of like, we’re gonna overcome this type of stuff? Because you had a lot more things to overcome than I did. So it’s like, how is that? How do you frame that in your head? Were you the kind of person who was like, ⁓ rehab’s around the corner, let’s do that? Or were you kind of reluctant? Judy Kim Cage (35:19) It was a combination of two things. One, I had been dying to go home. I said, I absolutely, why can’t I go home? I was in the hospital for three weeks before we moved to the rehab hospital. And once we had done that, I was there basically for the entire weekend and then they do evaluations on Tuesday. And so I was told on Tuesday that I would be there for another at least four to six weeks. And so that was even before therapies really began. So there was a part of me saying, I don’t care, let me go home and I’ll do outpatient every day and everything will be fine. At least I get to go home. But then the other part. Bill Gasiamis (35:52) Thanks. Judy Kim Cage (36:11) said, okay, well, once I realized I was stuck and that I couldn’t escape, I couldn’t go anywhere, ⁓ I actually, I did love therapy. ⁓ I loved being in speech therapy, being in OTE, being in PT even, because my girls were fantastic. They were so caring, so understanding. They made jokes and also laughed at mine, which was even better. And when you’re not in therapy, especially on the weekends, you’re just in your room by yourself. And you’re not watching TV because that input is way too heavy. Listening to music. maybe a little bit here and there. ⁓ You know, all the things that you know and love are nowhere to be found, you know, really. ⁓ Yeah, absolutely. Yeah, yeah. And I get claustrophobic in the MRI, in the hospital, et cetera. yeah. Bill Gasiamis (37:14) Oscillating. Yeah. I was on YouTube, searching YouTube videos that were about neuroplasticity, retraining the brain, that kind of stuff, meditations, type of thing. That really helped me on those weekends. The family was always around, but there was delays between family visits and what have you that couldn’t be there that entire time. ⁓ So I found that very interesting. And you know, rehab was a combination of frustration and excitement, excitement that I was getting the help, frustration that things weren’t moving as quickly as I wanted. ⁓ And I even remember the occupational therapist making us make breakfast. And I wouldn’t recommend this breakfast for stroke survivors. I think it was cereal and toast or something like that. And I remember being frustrated, why are they making me make it? My left side doesn’t work. Like I can barely walk. I cannot carry the glass with the tea or anything like that to me. What are these people doing? They should be doing it for us. I wasn’t aware. I wasn’t aware that that was part of the therapy. I just thought they were making us make our own bloody breakfast. I thought these people are so terrible. And it took a while for me to clue on like, ⁓ okay. Judy Kim Cage (38:44) you Bill Gasiamis (38:52) They want me to be able to do this when I get home. ⁓ understood. Took a while. I’m thick like that. Judy Kim Cage (39:00) Fortunately, wasn’t made to cook until close to the end. And also during outpatient, I was tasked to make kind of a larger, you know, crock pot dinner so that, you know, I could do that at home. Meanwhile, the irony of it all is that. I can cook and I used to love cooking, but I don’t do it nearly as much as I used to. So that skill did not really transfer over. ⁓ I have Post-it notes up by the microwave that tell me right hand only because if I use my left hand, the temperature differential I will burn myself ⁓ without even realizing it or even reaching for a certain part of a pan that I think is going to be safe and is somewhat heat resistant. And I touch it and then poof, well, you know, get a burn. So there are post-it notes everywhere. There’s one by the front door that says, watch the steps, because I had a couple of times flown down them and gashed my knee. Bill Gasiamis (40:13) Yeah. Judy Kim Cage (40:26) And it’s amazing actually how long a Post-It note with its temporary stick will stay up on a wall. Bill Gasiamis (40:35) Well, there’s another opportunity for you there, like do a project, ⁓ a longevity of Post-it Notes project, see how long we can get out of one application. Judy Kim Cage (40:46) Yeah, well, this one actually, so I think it was three months after I had moved in, which would have been 10 months into my stroke recovery. And that’s when I fell down these steps. And that’s when I put up the Post-It note. it has been, a piece of tape has been added to it. but it only fell down, I think, a couple of years ago. Bill Gasiamis (41:18) Yeah. So 3M need to shift their entire focus. I feel like 3M. Yeah. I think 3M needs to have a permanent ⁓ post-it note application, but easy to remove. if I want to take it down, like it’s permanent once I put it up, but if I want to take it down, it’s still easy to remove and it doesn’t ruin my paint or leave residue. Judy Kim Cage (41:44) They do actually have that tech. have it for, they call it command. It’s what they have for the hooks for photos and whatnot. And then if you pull the tab and then release it, it will come off and leave the wall undamaged, but it will otherwise stay there for a long. Bill Gasiamis (42:04) Yes, yes, I think you’re right. Most of the time it works, yes. Okay, well, we’re moving on to other things. You’ve overcome a lot of stuff. You’re dealing with a lot of stuff. And yet, you have this disposition, which is very chirpy and happy, go lucky. Is it real, that disposition, or is it just a facade? Using Humor in Moyamoya Syndrome and Stroke Recovery Judy Kim Cage (42:29) No, no, it’s real. It’s real. ⁓ I think I’ve always ⁓ tried to make light of things. ⁓ Humors, probably my first defense mechanism. ⁓ And I think that helped out a lot ⁓ in terms of recovery. And also, ⁓ it put my therapist in a great mood. Also, because not many people did that apparently. You know, most people curse them off or, you know, were kind of miserable. And there were times when I was miserable too. Absolutely. But, but I probably took it out more on my husband than I did the staff. And he, and he would call, you know, I said, I was so mean to you, Rich. was so mean to you. And he said, yeah, you were nicer to the nurses than to me. And I. I apologized for it, but at the same time I’m like, yeah, but sometimes, bud, you are so annoying. Bill Gasiamis (43:33) You had it coming. Judy Kim Cage (43:34) Yeah. Why are you so overprotective? Why do you point out every crack in the sidewalk? Why do you know, you still say I have to stop to tie up my hair when we’re walking on the sidewalk, you know, because you’re not supposed to do two things at once. ⁓ Yeah. So I felt as though I would make jokes all the time. I when my left hand would start to regain function. I called it my evil twin because I didn’t even recognize that it was mine. But then I would give it a high five every time I started gaining function back. And I would say things like, yeah, hey, evil twin, congrats. Or ⁓ I would say, I guess I don’t have to clean the house anymore. I don’t have to use my left hand to dust. I’m not capable of doing it. So why do it? Bill Gasiamis (44:29) Yeah. Judy Kim Cage (44:30) And I’m like, let’s always look for the silver lining. And it would usually be a joke. But, you know, if you couldn’t make fun of it or think about the ridiculousness of it, then I think it would be easier to fall into a pit of despair. Bill Gasiamis (44:48) I agree with you and laughing and all that releases, know, good endo, good endorphins and good neurochemicals and all that kind of stuff really does improve your blood pressure. It improves the way that your body feels, you know, the tightness in your muscles and all that kind of stuff. Everything improves when you laugh and you have to find funny things about a bad situation to laugh at, to kind of dial down the seriousness of the situation. can you know, really dial it down just by picking something strange that happened and laughing at it. I found myself doing that as well. And I’m similar in that I would go to rehab and they would, you know, we would chit chat like I am now with you and would have all sorts of conversations about all kinds of things. And the rehab was kind of like the, the, it was like the vessel, you know, to talk shit, have a laugh. ⁓ you know, be the clown of the rehab room. And I get it, everyone’s doing it tough, but it lightened the mood for everybody. You know, was, it’s a hard thing. You know, imagine it being just constantly and forever hard. And it was like, I don’t want to be that guy and wish they have fun as well. And, and I think my, my, my tough times were decreased as a result. Like, you know, those stuff, mental and emotional days, they, they come, but they go. then you have relief from them. And I think you need relief. Judy Kim Cage (46:23) Absolutely. Otherwise, just could feel perpetual and just never ending. ⁓ And why or how could you possibly survive feeling that way? Bill Gasiamis (46:39) Yeah. So who are you now? as in your, how does your idea of who you are sort of begin to shift after the initial acute phase and now six years in, almost seven years into your stroke journey? Finding Purpose After Stroke Judy Kim Cage (46:59) I think I am. I’m pretty confident in who I am, which is funny. ⁓ I ⁓ actually lean more into making more jokes or ⁓ lean into the fact that things don’t, they don’t have nearly the importance or the impact that you would otherwise think. ⁓ One of my sayings, I guess I say all the, you know, how they say don’t sweat the small stuff. my big stuff, like big stuff became small stuff, you know. So it would have to be something pretty big in order for me to really, really, you know, think about it. And a lot of the little things, you know, the nuisances in life and stuff, would usually just laugh or if I tripped or something, then I would just laugh at it and just keep moving on. ⁓ And I think, you know, It’s funny because some people will say, ⁓ gosh, like stop, you know, there is toxic positivity, right? And there’s plenty of that. And ⁓ I stay away from that, I think. But when I try to give people advice or a different outlook, ⁓ I do say, well, you you could think of it this way, you know. It’s not all sunshine and rainbows and flowers and, you know, care bears, but it is, you know, but it, but you can pull yourself out of a situation. You can try to figure out a way to work around it. You can, you know, choose differently for yourself, you know, do things that you love. You know, you’re only given a certain amount of limited time on the earth. So how do you want to spend it? And if you are on your deathbed, you know, would you have, do you have any regrets? You know, like you did read the books about, you know, that, ⁓ why am I forgetting? Doctors ⁓ that perform palliative care and, you know, they’ve written books about you know what people’s regrets have been after, know, once they are about to pass and you know, that not taking action was a regret. You know, like why didn’t I do this? Or why didn’t I do this? Why didn’t I try this? Like really, what would have been the downfall to trying something? ⁓ And I find that, you know, aside from just naturally being able to see things to laugh at or, or positive sides of things. ⁓ I tried, like, I wish that people could experience that without having gone through what we went through. ⁓ but that’s virtually impossible. I think. Bill Gasiamis (50:18) I think it’s impossible, totally, 100 % impossible because everybody thinks they’re doing okay until they’re not. You just cannot prevent somebody from going through something by taking the learning first. The learning has to come second. Sad as that is. Judy Kim Cage (50:39) ⁓ Well, and we all think we’re invincible to a large extent. ⁓ But ⁓ I think what I’ve been trying to do or me now, I’ve always, you know, volunteered in various ways, but now I take and hold extra value in being a mentor for other stroke patients. Bill Gasiamis (51:03) Yeah, yeah, that’s Judy Kim Cage (51:04) And for, you know, individuals that even just come up to me and talk about all of their medical problems, it doesn’t matter if it’s circulated or not, you know, it’s medically they’re like, there’s some white matter on my MRI, what do think I should do? I’m like, it’s not that simple of an answer. I think you should go to the doctor. Get on a list. Bill Gasiamis (51:29) Yeah. Your journey seems like you’re growing through this adversity, like as in it’s very post-traumatic growth type of experience here. Something that I talk about on my book, the unexpected way that a stroke became the best thing that happened. Not something that I recommend people experience to get to the other side of that, of course. But in hindsight, like it’s all those things that you’re describing. Judy’s Book: Super Survivor And I look at the chapters because in fact, you’ve written a book and it’s going to be out after this episode goes live, which is awesome. And the book that you’ve written is called Super Survivor. And indeed that is a fitting title. Indeed it is. How denial, resistance and persistence can lead to success and a better life after stroke. Right? So just looking at some of the chapters, there’s a lot of overlap there, right? And one of the chapters that there’s overlap in is the volunteering and purpose. I’ve got parts of my book that specifically talk about doing stuff for other people and how that supports recovery and how the people who said that stroke was the best thing that happened to them, the ones that I interviewed to gather the data, one of the main things that they were doing was helping other people, volunteering in some way, shape or form. And that helped shape their purpose in life. and their meaning in life. And it’s how I got there as well. It was like, okay, I’m gonna go and prevent stroke. I’m gonna go talk on behalf of the Stroke Foundation. We’re gonna raise awareness about what stroke is, how to take action on stroke, what to do if somebody’s having a stroke. And I started to feel like I gained a purpose in my life, which was gonna to not allow other people to go through what I went through. And then, With that came public speaking and then with that came the podcast and then the purpose grew and it became really ⁓ all encompassing. It’s like, wow, like I know what my mission is. I didn’t seek to find it. I stumbled across it and the chapter in my book is called stumbling into purpose because you can’t think it up. You just have to take action and then bam, bam, it appears. Like, is that your experience? Judy Kim Cage (53:53) ⁓ Well, so much of my identity had been wrapped up in my occupation. ⁓ And so when, you know, the stroke first happened, et cetera, but then as time has passed, ⁓ yeah, I’ve absolutely found more meaning in providing comfort to other stroke patients. whether it’s because they see me as inspiring that I was able to recover so quickly or that I was able to go back to work, you know, permanently. And just to give them hope, really. And ⁓ when I was in acute, I felt as though like, We do so much of the recovery alone ⁓ and there isn’t a ton of, you know, of course our therapists are fantastic and they’re, you know, they’re loving and they’re caring. But in terms of having to make it through, you know, certain darkness alone or, ⁓ you know, just feeling sorry for yourself even sometimes, or feeling like, hey, I can do everything, but nobody’s encouraging that. because they think it’s dangerous. ⁓ I had wished that, you know, there were more people who could understand ⁓ what survival and then recovery was, you know, truly like. And so I had read that in a number of books before hearing people tell me their stories in person because Emotionally, I absorbed too much of it. ⁓ I wanted to, I think I passed that five-year survival mark of the 26.7%, which I know varies for everybody. ⁓ at the same time, I said, wow, I did, I made it to the other side, I beat these odds. I think I wanted to keep it secret from all the people I worked with. which I still have actually, it won’t be for too much longer. ⁓ But ⁓ just being able to share that and to be vulnerable and to say all the deficits that I have and what I have overcome, ⁓ I think it’s also given people some hope that they can, if she was able to do it, then maybe it isn’t as tough as I think it is. Bill Gasiamis (56:43) Anyone can. Yeah, I love that. That’s kind of my approach to, you know, I’m just a average, humble, normal, amazing guy. You could do it too. You know, I could, I could teach you to what you need to do is learn. ⁓ but that’s true. It’s that it’s that we are, I get, I get people come on the podcast going, I’m so nervous to meet you. You’re on the, I’m on your podcast. Dude, you don’t know who I am. Like if you think I’m the podcast guy, you’ve got no idea. I’m in the back of my, in my garden, in a shed. what was something that’s meant to be a shed that looks like a studio and amazing and all this kind of stuff. Like, dude, I’m just. Judy Kim Cage (57:29) would not have known if you hadn’t told me. Bill Gasiamis (57:32) That’s right, because looks can be deceiving and that ideas that we get of people are just, you know, they’re just not accurate until we get to spend time with people and understand them. And I always try and play down who I am so that people can see that I am just a regular guy who went through this and had no, no equipment. had no ⁓ knowledge. had no skills overcoming learning. Like I just, I picked up what I needed when I could just so that I can stumble through to the next hurdle and stumble through that one and then keep going. I really want people to understand that even the people who appear to be super fabulous at everything, like they’re just not, nobody is that, everyone is just doing their best they can. Even the guy who’s got more money than you, a bigger house, whatever, a better investment, all that stuff, they’re all faking it until shit hits the fan and then they’ve got to really step up to be who they are. You know, that’s what I find. But attitude, mindset, ⁓ approach, know, laughing, doing things for other people all help. They are really important steps, you know. The other chapter that kind of. made me pay attention and take note ⁓ was you talk about the night everything changed, complicated medical history, lifesavers, volunteering and purpose, the caregivers, ⁓ easing back into life, which I think is a really important chapter, returning to work, which is really important. then chapter nine, life after stroke continued. That kind of really is something that made me pay attention because that’s exactly what it is, right? It’s life after stroke. It’s like a continuation. It’s a never ending kind of ⁓ unattainable thing. Judy Kim Cage (59:27) It just keeps rolling on. doesn’t stop. You know, even if you’ve gone through a hardship and overcome it, it doesn’t mean that life stops. You’ve got to keep learning these lessons over and over and over again. Even if you don’t want to learn them, however stubborn you are. ⁓ And I, you know, I one thing that I had written about was that I had resented ⁓ you know, what I had gone through for a little while. I said, why do I still have to learn the same lessons that everybody else has to learn? You know, if I’ve gone through this kind of transcendental thing, why do I still have to learn, you know, these other things? But then I realized that I was given the opportunity ⁓ from surviving, was given another chance to be able to truly realize what it was like to be happy and to live. And I’d never, I mean, I had, I had been depressed, you know, for an anxious for years. And, you know, I’ve been in therapy for years and, ⁓ you know, it really wasn’t truly until kind of getting this push of the fast forward button on learning lessons that it truly became happy, like true, true happiness. And I said, wow, that was the gift. And then to try to pass that on. Bill Gasiamis (1:01:10) It’s a pretty cool life hack. A shit way to experience it, but a pretty cool life hack. Judy Kim Cage (1:01:15) Yeah, yeah, yeah, definitely don’t I don’t recommend it I don’t Bill Gasiamis (1:01:20) Yeah. You get the learning in a short amount of time instead of years of years of wisdom and developing and learning and overcoming, which you avoided up until your first, you know, 38 years. And then, you know, you then, and then you kind of all of a sudden go, okay, well, I really have to buckle down and do these, ⁓ these modules of learning and I’ve got no choice. And I was the same. ⁓ and I have my days, I have my Good days, bad days, and I even recently had a bit of a day where I said to my wife, I got diagnosed with high blood pressure, headaches, migraines, a whole bunch of stuff, and then just tomorrow, I’m I’ve had enough. Why do I need to to be diagnosed with more things? Why do I need to have more medical appointments? Enough, it’s enough. I need to stop this stuff. It’s not fun. And then it took me about half a day to get over myself and go, well, I shouldn’t be here, really. Technically, Somebody has three blades in the brain, you know, I don’t know, maybe 50 years ago, they weren’t gonna make it. So now you’ve made it also high blood pressure. If you had high blood pressure 50 years ago, there was nothing to do to treat it. It was just gonna be high until you had a heart attack or ⁓ a brain aneurysm burst or something. And it’s like, I get to live in a time when interventions are possible and it is a blip on the radar. Like just all you do is take this tablet and you’re fine. Not that I revert to give me the tablet solution. I don’t, I’m forever going under the underlying cause. I want to know what the underlying cause is trying to get to the bottom of all of that. But in the meantime, I can remain stable with this little tablet and ⁓ decrease the risk of another brain hemorrhage. So it’s cool, know, like whatever. And that kind of helps me get through the, why me days, you know, cause They’re there, they come, they turn up, especially if it’s been one day after the next where things have been really unwell and we’ve had to medical help or whatever. When it’s been kind of intense version of it, it’s like, okay, I don’t want any more of this. So I get the whole, I’ve experienced the whole spectrum in this last 13, 14 years. We’re coming up to, I think the 20th or 21st, I think is my, maybe the 25th of my anniversary of my brain surgery. Jeez, I’ve come a long way. It’s okay. It’ll be like 11 years since my brain surgery. A lot of good things have happened since then. We got to live life for another 13 years, 11 years. I keep forgetting the number, it doesn’t matter. Yeah. Judy Kim Cage (1:04:17) Mine will have been my 17th ⁓ anniversary of my brain surgery ⁓ will be in January, sorry, in December. And then the seventh anniversary of the stroke is in January. So lot of years. Bill Gasiamis (1:04:33) Yeah, yeah. A lot of years, a lot of years, great that they’ve happened and I’m really happy with that. Keep doing these podcasts, makes me forget about myself. It’s about other people, so that’s cool. know, meet people like you, putting out awesome books. And when I was going through early on, there wasn’t a lot of content. It was hard to get content on stroke surviving, recovery, all the deficits, all the problems. That’s part of the reason why I started this. And now I think I’ve interviewed maybe 20 or 30 people who have written a book about stroke, which means that the access to information and stories is huge, right? So much of it. ⁓ Your book comes out in early December. Where is it going to be available for people to buy? Conclusion and Final Thoughts Judy Kim Cage (1:05:20) It is currently available to download ⁓ through the Kindle app and through Amazon. The hard copies will be available to order through Amazon and hopefully in other booksellers, but that’s TBD. Bill Gasiamis (1:05:39) Yeah, well, we’ll have all the current links by then. We’ll have all the current links available in the show notes. ⁓ At the beginning of this episode, I would have already talked about the book and in your bio when I’m describing the episode and who I’m about to chat to. So people would have already heard that once and hopefully they’ll be hearing it again at the end of the episode. So guys, if you didn’t pay attention at the beginning, but now you’re at the end, it’s about to come. I’m going to give all the details. Judy Kim Cage (1:06:07) stuck around. Bill Gasiamis (1:06:09) Yeah. If you stuck around, give us a thumbs up, right? Stuck around in the comments or something, you know? ⁓ Absolutely. Thank you so much for joining me, reaching out, sharing your story. It is lovely to hear and I wish you well in all of your endeavors, your continued recovery. yeah, fantastic. Great stuff. Thank you so much. Thank you. Well, that’s a wrap for another episode. want to thank Judy for sharing her story so openly. The way she spoke about denial, rehab, reality, cognitive fatigue and rebuilding identity is going to help a lot of people feel less alone. If you’re watching on YouTube, let us know in the comments, what part of Moyamoya Syndrome stroke recovery has been the hardest to explain to other people for you? Was it the physical symptoms or is it the invisible ones? like fatigue and cognition. And if you’re listening on Spotify or Apple podcasts, please leave a review. It really helps other stroke survivors find these conversations when they need them most. Judy’s book is called Super Survivor, How Denial Resistance and Persistence can lead to success and a better life after stroke. And you’ll find the links in the show notes. And if you want more support from me, you can Grab a copy of my book at recoveryafterstroke.com/book, and you can become a Patreon supporter at patreon.com/recoveryafterstroke. It genuinely helps keep this show alive. Thanks again for being here. Remember you’re not alone in this recovery journey and I’ll see you in the next episode. Importantly, we present many podcasts designed to give you an insight and understanding into the experiences of other individuals. Opinions and treatment protocols discussed during any podcast are the individual’s own experience and we do not necessarily share the same opinion nor do we recommend any treatment protocol discussed. All content on this website and any linked blog, podcast or video material controlled this website or content is created and produced for informational purposes only and is largely based on the personal experience of Bill Gasiamis The content is intended to complement your medical treatment and support healing. It is not intended to be a substitute for professional medical and should not be relied on as health advice. The information is general and may not be suitable for your personal injuries, circumstances or health objectives. Do not use our content as a standalone resource to diagnose, treat, cure or prevent any disease for therapeutic purposes or as a substitute for the advice of a health professional. Never delay seeking advice or disregard the advice of a medical professional, your doctor or your rehabilitation program based on our content. If you have any questions or concerns about your health or medical condition, please seek guidance from a doctor or other medical professional. If you are experiencing a health emergency or think you might be, call 000 if in Australia or your local emergency number immediately for emergency assistance or go to the nearest hospital emergency department. Medical information changes constantly. While we aim to provide current quality information in our content, we do not provide any guarantees and assume no legal liability or responsibility for the accuracy, currency or completeness of the content. If you choose to rely on any information within our content, you do so solely at your own risk. We are careful with links we provide. However, third party links from our website are followed at your own risk and we are not responsible for any information you find there. The post Moyamoya Syndrome Stroke Recovery: How Judy Rebuilt Her Life After a “Puff of Smoke” Diagnosis appeared first on Recovery After Stroke.
Studies show qigong can strengthen your body and mind, and reduce cortisol levels. We explore this Chinese meditative movement practice that dates back over 4,000 years.Summary: After a period of intense stress, loss, and physical disconnection, one guest turns to qigong—a gentle, meditative movement practice rooted in traditional Chinese medicine—to reconnect with their body and calm their nervous system. This episode of The Science of Happiness explores the growing scientific evidence behind qigong, revealing how mindful movement can support both physical health and psychological well-being.We want to hear from you! Take our 5-minute survey to enter a drawing to win a copy of The Science of Happiness Workbook: 10 Practices for a Meaningful Life. Tell us what you love, what you want more of, and how we can make the show even more inspiring and useful. Click the survey link in the show notes wherever you're listening, or go directly to: https://tinyurl.com/happyhappysurvey. Thank you for helping us make the podcast even better!One Way To Do This Practice: Stand and settle: Stand with your feet hip-width apart, knees soft, arms relaxed by your sides. Take a moment to feel the ground beneath your feet and let your body arrive. Ground through your feet: Gently rock or sway in small circles, slowly shifting your weight to notice different parts of your feet making contact with the floor. Let your balance find its own rhythm. Breathe slowly and naturally: Inhale through your nose and exhale through your mouth, allowing your breath to deepen without forcing it. Imagine your breath moving through your whole body, not just your chest. Begin gentle, flowing movements: Move your arms and torso in smooth, continuous motions—circling, swaying, or softly lifting and lowering your hands. Keep your movements relaxed and fluid rather than stiff or controlled. Soften your body and attention: Release unnecessary tension in your jaw, shoulders, and hands. Place your attention on how the movements feel from head to toe, letting your mind stay with sensation rather than thoughts. Close with stillness: After 10–15 minutes, return to standing quietly. Notice any changes in your energy, mood, or sense of grounding before stepping back into your day. Scroll down for a transcription of this episode.Today's Guests:ACE BORAL is an Oakland-based chef.PETER WAYNE is an Associate Professor of Medicine, and serves as the Director for the Osher Center for Integrative Medicine, jointly based at Harvard Medical School and Brigham and Women's Hospital.Learn more about Peter's work: https://tinyurl.com/342xndnaRelated The Science of Happiness episodes: Breathe Away Anxiety (Cyclic Sighing): https://tinyurl.com/3u7vsrr5The Science of Synchronized Movement: https://tinyurl.com/n4bcrb5jTell us about your experience with this practice. Email us at happinesspod@berkeley.edu or follow on Instagram @HappinessPod.Help us share The Science of Happiness! Leave us a 5-star review on Apple Podcasts and share this link with someone who might like the show: https://tinyurl.com/2p9h5aapTranscription: https://tinyurl.com/yyxnsfy9
We all want to stay sharp, and forestall the cognitive effects of aging. But do brain supplements actually work? Are they safe? And why doesn't the F.D.A. even know what's in them? (Part one of “The Freakonomics Radio Guide to Getting Better.”) SOURCES:Marty Makary, commissioner of the Food and Drug Administration.Peter Attia, physician, author, and host of The Peter Attia Drive.Pieter Cohen, associate professor of medicine at Harvard Medical School, physician at the Cambridge Health Alliance. RESOURCES:"Protein Powders and Shakes Contain High Levels of Lead," by Paris Martineau (Consumer Reports, 2025)."Accuracy of Labeling of Galantamine Generic Drugs and Dietary Supplements," by Pieter Cohen, Bram Jacobs, Koenraad Van Hoorde, and Céline Vanhee (JAMA, 2024).Blind Spots: When Medicine Gets It Wrong, and What It Means for Our Health, by Marty Makary (2024).Outlive: The Science and Art of Longevity, by Petter Attia (2023)."Revealing the hidden dangers of dietary supplements," by Jennifer Couzin-Frankel (Science, 2015). EXTRAS:"China Is Run by Engineers. America Is Run by Lawyers." by Freakonomics Radio (2025)."How to Fix the Hot Mess of U.S. Healthcare," by Freakonomics Radio (2021). Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
© 2020-2026 Ivy Podcast Discovery LLC
